Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

__________________________

FORM 10-Q

________________________________


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2023


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______ to ________

Commission File Number 001-38427

___________________________________________________________

Piedmont Lithium Inc.

(Exact name of Registrant as specified in its Charter)

_________________________________________________________________________________________


Delaware			36-4996461
(State or other jurisdiction of incorporation or organization)			(I.R.S. Employer Identification No.)
42 E Catawba Street Belmont, North Carolina			28012
(Address of principal executive offices)			(Zip Code)

Registrant’s telephone number, including area code: (704) 461-8000

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol

Name of each exchange on which registered

Common stock, $0.0001 par value per share

PLL

The Nasdaq Capital Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 (“Exchange Act”) during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☒

Accelerated filer

☐

Emerging growth company

☐

Non-accelerated filer

☐

Smaller reporting company

☐

☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of November 03, 2023, there were 19,209,327 shares of the Registrant’s common stock outstanding.

Table of Contents


			Page
Glossary of Terms and Definitions			3
PART I - Financial Information
	Item 1.	Financial Statements	4
		Consolidated Statements of Operations	4
		Consolidated Statements of Comprehensive Income (Loss)	5
		Consolidated Balance Sheets	6
		Consolidated Statements of Cash Flows	7
		Consolidated Statements of Changes in Equity	8
		Notes to the Consolidated Financial Statements	10
	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	22
	Item 3.	Quantitative and Qualitative Disclosures About Market Risk	30
	Item 4.	Controls and Procedures	31

PART II - Other Information
	Item 1.	Legal Proceedings	32
	Item 1A.	Risk Factors	32
	Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	33
	Item 3.	Defaults Upon Senior Securities	33
	Item 4.	Mine Safety Disclosures	33
	Item 5.	Other Information	33
	Item 6.	Exhibits	34

Signatures			35

Table of Contents

GLOSSARY OF TERMS AND DEFINITIONS

When the following terms and abbreviations appear in the text of this report, they have the meanings indicated below:


Air Permit			Conditional Major Non-Title V Construction and Operating Air Permit
ASX			Australian Securities Exchange
Atlantic Lithium			Atlantic Lithium Limited
Atlantic Lithium Ghana			Atlantic Lithium’s Ghanaian-based lithium portfolio companies
ATVM			Advanced Technology Vehicles Manufacturing Loan Program
Benton Resources			Benton Resources Inc.
Carolina Lithium			The Carolina Lithium project is Piedmont Lithium’s planned, integrated spodumene-to-lithium hydroxide project located within the renowned Carolina Tin Spodumene Belt in Gaston County, North Carolina
CODM			Chief Operating Decision Maker
DEMLR			Department of Energy, Mineral and Land Resources
DFS			Definitive feasibility study
dmt			Dry metric ton
DOE			U.S. Department of Energy

Ewoyaa			The Ewoyaa Lithium Project is the flagship project of Atlantic Lithium Ghana located in the Cape Coast region of West Africa, Ghana
Exchange Act			Securities Exchange Act of 1934
FDIC			Federal Deposit Insurance Corporation

Incentive Plan			Piedmont Lithium Inc. Stock Incentive Plan

LG Chem			LG Chem, Ltd.
Li2O			Lithium oxide

MIIF			Minerals Income Investment Fund of Ghana
Milestone PRAs			PRAs that could be earned based upon achievement of certain specified milestones
NAL			North American Lithium Inc.
NCDEQ			North Carolina Department of Environmental Quality
Piedmont Lithium Inc.			“Piedmont Lithium,” “we,” “our,” “us,” or “Company”
PRAs			Performance rights awards
Ricca			Ricca Resources Limited
RSUs			Restricted stock units
Sayona Mining			Sayona Mining Limited
Sayona Quebec			Sayona Quebec Inc.
SEC			Securities and Exchange Commission
Sokoman Minerals			Sokoman Minerals Corp.
spodumene concentrate			Spodumene concentrate or SC[X] where “X” represents the lithium content of the concentrate on an Li2O% basis
TDEC			Tennessee Department of Environment and Conservation
Tennessee Lithium			The Tennessee Lithium project is Piedmont Lithium’s planned 30,000 tons per year lithium hydroxide conversion facility project located in Etowah, Tennessee
TSR PRAs			PRAs related to market goals based on a comparison of the Company's total shareholder return relative to the total shareholder return of a pre-determined set of peer group companies for the performance periods
U.S.			United States of America
U.S. GAAP			U.S. Generally Accepted Accounting Principles
Vinland Lithium			Vinland Lithium Inc.

Table of Contents

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements.

PIEDMONT LITHIUM INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts) (Unaudited)


	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Revenue	$	47,127	$	—	$	47,127	$	—
Costs of sales	23,363		—		23,363		—
Gross profit	23,764		—		23,764		—

Exploration and mine development costs	471		434		1,668		1,485
Selling, general, and administrative expenses	11,185		7,160		31,793		20,200
Total operating expenses	11,656		7,594		33,461		21,685
Income (loss) from equity method investments(1)	3,852		(2,003)		(1,565)		(6,547)
Income (loss) from operations	15,960		(9,597)		(11,262)		(28,232)

Interest income	1,031		373		2,959		373
Interest expense	(8)		(21)		(34)		(97)
Loss from foreign currency exchange	(22)		(35)		(88)		(60)
Gain on dilution of equity method investments(1)	7,958		29,367		15,208		29,367
Total other income	8,959		29,684		18,045		29,583
Income before taxes	24,919		20,087		6,783		1,351
Income tax expense	2,028		3,422		3,170		3,422
Net income (loss)	$	22,891	$	16,665	$	3,613	$	(2,071)

Earnings (loss) per share:
Basic	$	1.19	$	0.93	$	0.19	$	(0.12)
Diluted	$	1.19	$	0.92	$	0.19	$	(0.12)
Weighted-average shares outstanding
Basic	19,203		17,966		18,974		17,343
Diluted	19,239		18,081		19,011		17,343

__________________________

(1)Income (loss) from equity method investments and Gain on dilution of equity method investments are reported on a one-quarter lag.

The accompanying notes are an integral part of these unaudited financial statements.

Table of Contents

PIEDMONT LITHIUM INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(In thousands) (Unaudited)


	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Net Income (loss)	$	22,891	$	16,665	$	3,613	$	(2,071)
Other comprehensive income (loss), net of tax:

Foreign currency translation adjustment of equity method investments(1)	(2,992)		811		(4,084)		662
Other comprehensive income (loss), net of tax	(2,992)		811		(4,084)		662
Comprehensive income (loss)	$	19,899	$	17,476	$	(471)	$	(1,409)

__________________________

(1)Foreign currency translation adjustment of equity method investments is presented net of tax (expense) benefit of $264 and $(392) for the three months ended September 30, 2023, and 2022 respectively, and $830 and $(392) for the nine months ended September 30, 2023, and 2022 respectively.

The accompanying notes are an integral part of these unaudited financial statements.

Table of Contents

PIEDMONT LITHIUM INC.

CONSOLIDATED BALANCE SHEETS

(In thousands)


	(Unaudited)
	September 30, 2023		December 31, 2022
Assets
Cash and cash equivalents	$	94,495	$	99,247
Accounts receivable	23,281		—

Other current assets	4,374		2,612
Total current assets	122,150		101,859
Property, plant and mine development, net	116,422		71,541

Other non-current assets	25,734		18,873
Equity method investments	133,044		95,648
Total assets	$	397,350	$	287,921

Liabilities and Stockholders’ Equity


Accounts payable and accrued expenses	$	34,607	$	12,862
Current portion of long-term debt	201		425
Other current liabilities	8,052		124
Total current liabilities	42,860		13,411
Long-term debt, net of current portion	44		163
Operating lease liabilities, net of current portion	1,174		1,177
Deferred tax liabilities	5,221		2,881
Total liabilities	49,299		17,632
Commitments and contingencies (Note 12)
Stockholders’ equity:
Common stock; $0.0001 par value, 100,000 shares authorized; 19,209 and 18,073 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively	2		2
Additional paid-in capital	459,475		381,242
Accumulated deficit	(102,045)		(105,658)
Accumulated other comprehensive loss	(9,381)		(5,297)
Total stockholders’ equity	348,051		270,289
Total liabilities and stockholders’ equity	$	397,350	$	287,921

The accompanying notes are an integral part of these unaudited financial statements.

Table of Contents

PIEDMONT LITHIUM INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands) (Unaudited)


	Nine Months Ended September 30,
	2023		2022
Cash flows from operating activities:
Net Income (loss)	$	3,613	$	(2,071)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Stock-based compensation expense	7,378		2,643
Loss from equity method investments	1,565		6,547
Gain on dilution of equity method investments	(15,208)		(29,367)
Deferred taxes	3,170		3,422
Depreciation	174		32
Noncash lease expense	169		72
Loss on sale of property, plant and mine development	—		12
Unrealized loss on investment	27		54
Changes in operating assets and liabilities:
Accounts receivable	(23,281)		—

Other assets	(1,633)		(959)
Operating lease liabilities	(148)		(69)
Accounts payable	21,865		270
Accrued expenses and other current liabilities	7,712		(2,627)
Net cash provided by (used in) operating activities	5,403		(22,041)
Cash flows from investing activities:

Capital expenditures	(44,978)		(21,892)
Advances to affiliates	(6,828)		(9,815)
Investments in equity method investments	(28,667)		(14,087)
Net cash used in investing activities	(80,473)		(45,794)
Cash flows from financing activities:
Proceeds from issuances of common stock, net of issuance costs	71,084		122,059
Proceeds from exercise of stock options	—		93
Principal payments on long-term debt	(344)		(973)
Payments to tax authorities for employee stock-based compensation	(422)		—
Net cash provided by financing activities	70,318		121,179
Net (decrease) increase in cash	(4,752)		53,344
Cash and cash equivalents at beginning of period	99,247		64,245

Cash and cash equivalents at end of period	$	94,495	$	117,589

Supplemental disclosure of cash flow information:
Noncash capital expenditures in accounts payable and accrued expenses	$	5,114	$	2,227

Cash paid for interest	34		97
Capitalized stock-based compensation	193		213

The accompanying notes are an integral part of these unaudited financial statements.

Table of Contents

PIEDMONT LITHIUM INC.

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

(In thousands) (Unaudited)


	Common Stock			Additional Paid-In Capital		Accumulated Deficit		Accumulated Other Comprehensive Loss		Total Stockholders’ Equity
	Shares	Amount
December 31, 2022	18,073	$	2	$	381,242	$	(105,658)	$	(5,297)	$	270,289
Issuance of common stock, net	1,097	—		71,084		—		—		71,084
Stock-based compensation, net of forfeitures	—	—		1,166		—		—		1,166
Shares issued for exercise/vesting of share-based compensation awards	13	—		—		—		—		—


Equity method investment adjustments in other comprehensive loss, net of tax	—	—		—		—		(2,213)		(2,213)
Net loss	—	—		—		(8,639)		—		(8,639)
March 31, 2023	19,183	$	2	$	453,492	$	(114,297)	$	(7,510)	$	331,687

Stock-based compensation, net of forfeitures	—	—		3,266		—		—		3,266
Shares issued for exercise/vesting of share-based compensation awards	13	—		—		—		—		—


Equity method investment adjustments in other comprehensive income, net of tax	—	—		—		—		1,121		1,121
Net loss	—	—		—		(10,639)		—		(10,639)
June 30, 2023	19,196	$	2	$	456,758	$	(124,936)	$	(6,389)	$	325,435

Stock-based compensation, net of forfeitures	—	—		3,139		—		—		3,139
Shares issued for exercise/vesting of share-based compensation awards	24	—		—		—		—		—
Shares surrendered for tax obligations for share-based transactions	(11)	—		(422)		—		—		(422)

Equity method investment adjustments in other comprehensive income (loss), net of tax	—	—		—		—		(2,992)		(2,992)
Net income	—	—		—		22,891		—		22,891
September 30, 2023	19,209	$	2	$	459,475	$	(102,045)	$	(9,381)	$	348,051

The accompanying notes are an integral part of these unaudited financial statements.

Table of Contents

PIEDMONT LITHIUM INC.

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

(In thousands)(Unaudited)


	Common Stock			Additional Paid-In Capital		Accumulated Deficit		Accumulated Other Comprehensive Loss		Total Stockholders’ Equity
	Shares	Amount
December 31, 2021	15,894	$	2	$	255,132	$	(92,683)	$	(666)	$	161,785
Issuance of common stock, net	2,013	—		122,059		—		—		122,059
Stock-based compensation, net of forfeitures	—	—		(86)		—		—		(86)
Shares issued for exercise/vesting of share-based compensation awards	23	—		—		—		—		—


Equity method investment adjustments in other comprehensive income, net of tax	—	—		—		—		194		194
Net loss	—	—		—		(9,155)		—		(9,155)
March 31, 2022	17,930	$	2	$	377,105	$	(101,838)	$	(472)	$	274,797

Stock-based compensation, net of forfeitures	—	—		1,591		—		—		1,591
Shares issued for exercise/vesting of share-based compensation awards	35	—		94		—		—		93


Equity method investment adjustments in other comprehensive loss, net of tax	—	—		—		—		(343)		(343)
Net loss	—	—		—		(9,581)		—		(9,581)
June 30, 2022	17,965	$	2	$	378,790	$	(111,419)	$	(815)	$	266,558
Stock-based compensation, net of forfeitures	—	—		1,350		—		—		1,350
Shares issued for exercise/vesting of share-based compensation awards	30	—		—		—		—		—
Equity method investment adjustments in other comprehensive income, net of tax	—	—		—		—		811		811
Net income	—	—		—		16,665		—		16,665
September 30, 2022	17,995	$	2	$	380,140	$	(94,754)	$	(4)	$	285,384

The accompanying notes are an integral part of these unaudited financial statements.

Table of Contents

PIEDMONT LITHIUM INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1.DESCRIPTION OF COMPANY

Nature of Business

Piedmont Lithium Inc. (“Piedmont Lithium,” “we,” “our,” “us,” or “Company”) is a U.S. based, development-stage, multi-asset, integrated lithium business in support of a clean energy economy and U.S. and global energy security. We plan to supply lithium hydroxide to the electric vehicle and battery manufacturing supply chains in North America by processing spodumene concentrate produced from assets we own or in which we have an economic interest.

Our portfolio of wholly owned projects includes Tennessee Lithium, a proposed merchant lithium hydroxide manufacturing plant in McMinn County, Tennessee, and Carolina Lithium, a proposed, fully integrated spodumene concentrate-to-lithium hydroxide project in Gaston County, North Carolina. The balance of our project portfolio includes strategic investments in lithium assets in Quebec, Canada, including the operating NAL mine, and in Ghana, West Africa with Atlantic Lithium, including Ewoyaa.

Basis of Presentation

Our unaudited consolidated financial statements and related notes have been prepared on the accrual basis of accounting in conformity with U.S. GAAP and in conformity with the rules and regulations of the SEC. The unaudited consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Our reporting currency is U.S. dollars, and we operate on a calendar fiscal year. Certain information and note disclosures normally included in the consolidated financial statements prepared in accordance with U.S. GAAP have been omitted pursuant to such rules and regulations. Therefore, these unaudited interim consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in our amended Annual Report on Form 10-K/A for the year ended December 31, 2022. These unaudited consolidated financial statements reflect all adjustments and reclassifications that, in the opinion of management, are considered necessary for a fair statement of the results of operations, financial position, and cash flows for the periods presented. The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the year ending December 31, 2023, for any other interim period, or for any other future fiscal year.

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, assumptions, and allocations that affect amounts reported in the consolidated financial statements and related notes. Significant items that are subject to such estimates and assumptions include, but are not limited to, long-lived assets, fair value of stock-based compensation awards, income tax uncertainties, valuation of deferred tax assets, contingent assets and liabilities, legal claims, asset impairments, provisional revenue adjustments, collectability of receivables and environmental remediation. Actual results could differ due to the uncertainty inherent in the nature of these estimates.

We base our estimates and assumptions on current facts, historical experience, and various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. Actual results may differ materially and adversely from our estimates. To the extent there are material differences between estimates and actual results, future results of operations will be affected.

Risk and Uncertainties

We are subject to a number of risks similar to those of other companies of similar size in our industry, including but not limited to, the success of our exploration and development activities, success of our equity method investments in international projects, permitting and construction delays, the need for additional capital or financing to fund operating losses, competition from substitute products and services, protection of proprietary technology, litigation, and dependence on key individuals.

We have accumulated deficits of $102.0 million and $105.7 million as of September 30, 2023 and December 31, 2022, respectively. We have cash available on hand and believe this cash will be sufficient to fund our operations and meet our obligations as they come due for at least one year from the date these unaudited consolidated financial statements are issued. In the event our cash requirements change during the next twelve months, management has the ability and commitment to make corresponding changes to our operating

Table of Contents

expenses, capital expenditures, and investments as necessary. Until commercial production is achieved from our planned operations, we will continue to incur investing net cash outflows associated with, among other things, funding capital projects, development-stage technical studies, permitting activities associated with our projects, funding our expected commitments in Quebec and Ghana, maintaining and acquiring exploration properties and undertaking ongoing exploration activities. Our long-term success is dependent upon our ability to successfully raise additional capital or financing or enter into strategic partnership opportunities. Our long-term success is also dependent upon our ability to obtain certain permits and approvals, develop our planned portfolio of projects, earn revenues, and achieve profitability.

Our unaudited consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.

Significant Accounting Policies

Revenue Recognition

We recognize revenue from product sales at a point in time when performance obligations are satisfied under the terms of contracts with our customers. A performance obligation is deemed to be satisfied when control of the product is transferred to our customer, which is typically upon delivery to the shipping carrier. Where a contract contains more than one distinct performance obligation, the transaction price is allocated to each performance obligation based on the standalone selling price of each performance obligation, although these situations do not occur frequently and are generally not built into our contracts. Revenue is measured as the amount of consideration expected to be received in exchange for transferring the goods. Initial pricing is typically billed 5 days to 30 days after the departure of the shipment and paid between 15 days to 75 days. Final adjustments to prices may take longer to resolve. When the final price has not been resolved by the end of a reporting period, we estimate the expected sales price based on the initial price, market pricing and known quality measurements. We warrant to our customers that our products conform to mutually agreed product specifications.

We have elected to account for shipping and handling costs for spodumene concentrate contracts as fulfillment activities and not as promised goods or services; therefore, these activities are not considered separate performance obligations. We have elected the practical expedient relating to significant financing components and as such will not consider the possibility of a contract having a significant financing component (which would effectively attribute a portion of the sales price to interest income) unless, if at contract inception, the expected payment terms (from time of delivery or other relevant criterion) are more than one year.

Our lithium products are sold to global and regional customers in the electric vehicle and electronics markets, among others. We currently work with end users in a number of markets to tailor our products to their specifications and will work with these end users as we add more products.

There have been no other changes to significant accounting policies described in Note 2—Summary of Significant Accounting Policies within Part II, Item 8 of our Annual Report for the year ended December 31, 2022.

Recently Issued and Adopted Accounting Pronouncements

We have considered the applicability and impact of all recently issued accounting pronouncements and have determined that they were either not applicable or were not expected to have a material impact on our unaudited consolidated financial statements.

2.REVENUE

We recognize revenue from product sales at a point in time when performance obligations are satisfied under the terms of contracts with our customers. A performance obligation is deemed to be satisfied when control of the product is transferred to our customer, which is typically upon delivery to the shipping carrier. There currently are no contracts with multiple performance obligations and there have been no unsatisfied performance obligations. Revenue is measured as the amount of consideration expected to be received in exchange for transferring the goods. Initial pricing is typically billed 5 days to 30 days after the departure of the shipment and paid between 15 days to 75 days. Final adjustments to prices may take longer to resolve. When the final price has not been resolved by the end of a reporting period, we estimate the expected sales price based on the initial price, market pricing and known quality measurements. We warrant to our customers that our products conform to mutually agreed product specifications.

In the three and nine months ended September 30, 2023, two customers accounted for 100% of total revenue. All of the sales related to these two customers originated in North America. We evaluate the collectability of our accounts receivable on an individual customer basis. We had no reserve for uncollectible accounts as of September 30, 2023.

Table of Contents

There are no contract assets or contract liabilities as of September 30, 2023.

We are subject to provisional revenue adjustments associated with commodity price fluctuations for our spodumene concentrate sales. These adjustments are unknown until final settlement.

3.STOCK-BASED COMPENSATION

Stock Incentive Plans

The Incentive Plan authorizes the grant of stock options, stock appreciation rights, restricted stock units, and restricted stock, any of which may be performance-based. Our Leadership and Compensation Committee determines the exercise price for stock options and the base price of stock appreciation rights, which may not be less than the fair market value of our common stock on the date of grant. Generally, stock options or stock appreciation rights vest after three years of service and expire at the end of ten years. PRAs vest upon achievement of certain pre-established performance targets that are based on specified performance criteria over a performance period. As of September 30, 2023, 2,143,116 shares of common stock were available for issuance under our Incentive Plan.

We include the expense related to stock-based compensation in the same financial statement line item as cash compensation paid to the same employee. As of September 30, 2023, we had remaining unvested stock-based compensation expense of $10.9 million to be recognized through December 2025. Additionally, and if applicable, we capitalize personnel expenses attributable to the development of our mine and construction of our plants, including stock-based compensation expenses. We recognize share-based award forfeitures as they occur.

Stock-based compensation related to all stock-based incentive plans is presented in the following table:


	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
Components of stock-based compensation:
Stock-based compensation	$	3,139	$	1,358	$	7,576	$	3,715
Stock-based compensation forfeitures	—		(8)		(5)		(859)
Stock-based compensation, net of forfeitures	$	3,139	$	1,350	$	7,571	$	2,856

Presentation of stock-based compensation in the unaudited consolidated financial statements:
Exploration and mine development costs	$	57	$	131	$	128	$	133
Selling, general, and administrative expenses	3,010		1,129		7,250		2,510
Stock-based compensation expense, net of forfeitures(1)	3,067		1,260		7,378		2,643
Capitalized stock-based compensation(2)	72		90		193		213
Stock-based compensation, net of forfeitures	$	3,139	$	1,350	$	7,571	$	2,856

__________________________

(1)For the three and nine months ended September 30, 2023 and 2022, we did not reflect tax impacts associated with stock-based compensation expense in our consolidated statements of operations because we had a full tax valuation allowance in impacted jurisdictions during these periods.

(2)Capitalized stock-based compensation relates to direct labor costs associated with Carolina Lithium and Tennessee Lithium and is included in “Property, plant and mine development, net” in our consolidated balance sheets.

Table of Contents

A summary of activity related to our share-based awards is presented in the following table:


	2023			2022
(in thousands)	Stock Option Awards	Restricted Stock Units	Performance Rights Awards	Stock Option Awards	Restricted Stock Units	Performance Rights Awards
Balance at January 1	265	36	44	273	51	30
Granted	42	40	42	136	17	29
Exercised, surrendered or vested	—	(13)	—	(15)	(14)	—
Forfeited or expired	—	(1)	—	(20)	(17)	—
Balance at March 31	307	62	86	374	37	59
Granted	30	31	27	59	8	10
Exercised, surrendered or vested	—	(12)	—	(38)	(9)	—

Balance at June 30	337	81	113	395	36	69
Granted	—	—	—	—	3	10
Exercised, surrendered or vested	(2)	—	(22)	(37)	(1)	—
Forfeited or expired	—	—	—	—	(1)	—
Balance at September 30	335	81	91	358	37	79

Stock Option Awards

Stock options may be granted to employees, officers, non-employee directors and other service providers. For stock option awards, the fair value is estimated at the date of grant using the Black-Scholes valuation model and the expense is recognized over the option vesting period.

Restricted Stock Unit Awards

RSUs are granted to employees and non-employee directors and recognized as stock-based compensation expense over the vesting period, subject to the passage of time and continued service during the vesting period, based on the market price of our common stock on the grant date. In some instances, awards may vest concurrently with or following an employee’s termination.

Performance Rights Awards

As of September 30, 2023, there were 22,000 unvested Milestone PRAs and 69,000 unvested TSR PRAs. The awards become eligible to vest only if the goals are achieved and will vest only if the grantee remains employed by the Company through each applicable vesting date. Each performance right converts into one share of common stock upon vesting of the performance right.

We determine the fair value of Milestone PRAs based upon the market price of our common stock on the grant date. Milestone PRAs are subject to certain milestones related to construction, feasibility studies, and offtake agreements, which must be satisfied in order for PRAs to vest.

We estimate the fair value of the TSR PRAs at the grant date using a Monte Carlo simulation. The Monte Carlo simulation fair value model requires the use of highly subjective and complex assumptions, including price volatility of the underlying stock. A Monte Carlo simulation model was used to determine the grant date fair value by simulating a range of possible future stock prices for the Company and each member of the peer group over the performance periods. Compensation expense is recognized based upon the assumption of 100% achievement of the TSR goal and is reflected over the service period of the award. Compensation expense will not be reversed even if the threshold level of TSR is never achieved. The number of shares that may vest ranges from 0% to 200% of the target amount. The awards, which range from 1 year to 3 years, provide for a partial payout based on actual performance at the conclusion of the performance period.

Each performance right converts into one share of common stock upon vesting of performance right.

Table of Contents

4.EARNINGS PER SHARE

We compute basic and diluted earnings per common share by dividing net earnings by the respective weighted average number of common shares outstanding for the periods presented. Our calculation of diluted earnings per common share also includes the dilutive effects for the assumed vesting of outstanding options, RSUs, and PRAs based on the treasury stock method. In computing diluted earnings per share, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options. Diluted earnings per share excludes all dilutive potential shares if their effect is anti-dilutive.

Basic and diluted net income (loss) per share is reflected in the following table:


	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands, except per share amounts)	2023		2022		2023		2022
Net income (loss)	$	22,891	$	16,665	$	3,613	$	(2,071)

Weighted-average number of common shares used in calculating basic earnings per share	19,203		17,966		18,974		17,343


Effect of potentially dilutive equity awards	36		115		37		—
Weighted-average number of common shares used in calculating dilutive earnings per share	19,239		18,081		19,011		17,343

Basic net income (loss) per weighted-average share	$	1.19	$	0.93	$	0.19	$	(0.12)
Diluted net income (loss) per weighted-average share	$	1.19	$	0.92	$	0.19	$	(0.12)

Potentially dilutive shares were not included in the calculation of diluted net loss per share because their effect would have been anti-dilutive in those periods. PRAs were not included as their performance obligations had not been met. The potentially dilutive and anti-dilutive shares not included in diluted net loss per share are presented in the following table:


	Three Months Ended September 30,		Nine Months Ended September 30,
(in thousands)	2023	2022	2023	2022
Stock options	294	223	71	358
RSUs	3	3	10	37
PRAs	94	79	88	79
Total potentially dilutive shares	391	305	169	474

5.INCOME TAXES

We recorded income tax expense of $2.0 million on income before taxes of $24.9 million and a provision of $3.4 million on income before taxes of $20.1 million in the three months ended September 30, 2023 and 2022, respectively. We recorded income tax expense of $3.2 million on income before taxes of $6.8 million and a provision of $3.4 million on income before taxes of $1.4 million in the nine months ended September 30, 2023 and 2022, respectively. The effective tax rates were 8.1% and 17% in the three months ended September 30, 2023 and 2022, respectively, and 46.7% and 253.3% in the nine months ended September 30, 2023 and 2022, respectively.

The decrease in income tax expense for the three and nine months ended September 30, 2023 as compared to the three and nine months ended September 30, 2022 was primarily due to a decrease in the gain on dilution in Sayona Mining during the three and nine months ended September 30, 2023. The effective tax rate differs from the U.S. federal statutory rate due to the valuation allowance against our U.S. deferred tax assets and income in foreign jurisdictions taxed at different rates than the U.S. statutory tax rate.

We intend to continue maintaining a valuation allowance on our deferred tax assets until there is sufficient evidence to support the reversal of all or some portion of the allowance. However, given our anticipated future earnings, we believe that there is a reasonable possibility that within the next 12 months, sufficient positive evidence may become available to allow us to reach a conclusion that a material portion of the valuation allowance will no longer be needed. Release of the valuation allowance would result in the recognition of certain deferred tax assets and a decrease in income tax expense for the period in which the release is recorded. The exact timing and amount of the valuation allowance release are subject to change based on the level of profitability that we are able to

Table of Contents

achieve. We continually review the adequacy of our valuation allowance and intend to maintain a valuation allowance on our deferred tax assets where there is not sufficient evidence to support realizability.

6.PROPERTY, PLANT AND MINE DEVELOPMENT

Property, plant and mine development, net, is presented in the following table:


(in thousands)	September 30, 2023		December 31, 2022
Mining interests	$	78,623	$	56,120
Mine development	4,971		3,050
Land	720		720
Leasehold improvements	401		281
Facilities and equipment	915		675
Construction in process	31,051		10,780
Property, plant and mine development	116,681		71,626
Accumulated depreciation	(259)		(85)
Property, plant and mine development, net	$	116,422	$	71,541

Mining interests and mine development costs relate to Carolina Lithium. Our construction in process primarily relates to capitalized costs associated with Tennessee Lithium.

Depletion of mining interests and mine development assets does not commence until the assets are placed in service. As of September 30, 2023, we have not recorded depletion expense for any of our mining interests or mine development assets.

Depreciation expense is included in “Selling, general and administrative expenses” in our consolidated statements of operations as follows:


	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
Depreciation expense	$	68	$	21	$	174	$	32

7.EQUITY METHOD INVESTMENTS

We apply the equity method to investments when we have the ability to exercise significant influence over the operational decision-making authority and financial policies of the investee. We account for our existing investments in Atlantic Lithium, Sayona Mining, and Sayona Quebec, a subsidiary of Sayona Mining, as equity method investments.

We continue to evaluate operational developments and the impact of the anticipated expansion of the operations of our existing equity method investees. As discussed below, Atlantic Lithium’s completion of a technical study for Ewoyaa, along with the restart of NAL, were impactful to the consideration of how we most appropriately reflect our proportional share of income (loss) from our three existing equity method investments. Offtake agreements with our equity method investees are expected to initially supply spodumene concentrate, which may be resold into the market. Upon completion of construction of Tennessee Lithium, our equity method investees are expected to supply the majority of the spodumene concentrate required by Tennessee Lithium for conversion to lithium hydroxide.

Our share of the income (loss) from Atlantic Lithium, Sayona Mining, and Sayona Quebec is recorded on a one-quarter lag in “Income (loss) from equity method investments” within “Income (loss) from operations” in our consolidated statements of operations.

Below is a summary of our equity method investments as of September 30, 2023.

Table of Contents

Sayona Mining

We own an equity interest of approximately 12% in Sayona Mining, an Australian company publicly listed on the ASX, and have formed a strategic partnership with Sayona Mining to explore, evaluate, develop, mine, and produce spodumene concentrate in Quebec, Canada.

During the nine months ended September 30, 2023 and 2022, we reported the effects of Sayona Mining raising additional capital through share issuances of its common stock. We did not participate in these share issuances, which were issued at a valuation greater than the carrying value of our ownership interest. As a result, our ownership interest in Sayona Mining was diluted and declined. We recognized a noncash gain of $8.0 million and $29.4 million in the three months ended September 30, 2023 and 2022, respectively, and $15.2 million and $29.4 million in the nine months ended September 30, 2023, and 2022, respectively, related to the dilution of our ownership interest. We recorded the gain within “Gain on dilution of equity method investments” in our consolidated statements of operations.

Sayona Quebec

We own an equity interest of 25% in Sayona Quebec for the purpose of furthering our investment and strategic partnership in Quebec, Canada. The remaining 75% equity interest is held by Sayona Mining. Sayona Quebec holds a 100% interest in NAL, which consists of a surface mine and a concentrator plant, as well as the Authier Lithium Project and the Tansim Lithium Project.

We hold a life-of-mine offtake agreement with Sayona Quebec for the greater of 113,000 metric tons or 50% of spodumene concentrate production per year. Our purchases of spodumene concentrate from Sayona Quebec are subject to market pricing with a price floor of $500 per metric ton and a price ceiling of $900 per metric ton for 6.0% spodumene concentrate on an FOB North Carolina basis.

In addition to lithium mining and concentrate production, NAL owns a partially completed lithium carbonate plant, which was developed by a prior operator of NAL. Sayona Quebec completed a preliminary technical study for the completion and restart of the NAL carbonate plant during the quarter ended June 30, 2023. If we decide to construct and operate a lithium conversion plant with Sayona Mining through our joint venture, Sayona Quebec, spodumene concentrate produced from NAL would be preferentially delivered to that conversion plant upon commencement of conversion operations. Any remaining spodumene concentrate not delivered the conversion plant would first be sold to us up to our offtake right and then to third parties. Any decision to construct jointly-owned lithium conversion capacity must be agreed upon by both parties.

Atlantic Lithium

We own an equity interest of approximately 9% in Atlantic Lithium, an Australian company publicly listed on the Alternative Investment Market of the London Stock Exchange and the ASX. We have a strategic partnership with Atlantic Lithium to explore, evaluate, mine, develop, and ultimately produce spodumene concentrate in Ghana. We have the right to acquire up to a 50% equity interest in Atlantic Lithium Ghana, a subsidiary of Atlantic Lithium that owns Ewoyaa, through current and future phased investments.

We have a long-term offtake agreement whereby Atlantic Lithium will sell 50% of spodumene concentrate produced in Ghana for the life of the mine to Piedmont Lithium at market prices. See Note 8—Other Assets and Liabilities.

Table of Contents

The following tables summarize the carrying amounts, including changes therein, of our equity method investments:


	Three Months Ended September 30, 2023
(in thousands)	Sayona Mining		Sayona Quebec		Atlantic Lithium		Total
Balance at June 30, 2023	$	47,283	$	66,546	$	10,211	$	124,040
Additional investments	450		—		—		450

Gain on dilution of equity method investments(1)	7,894		—		64		7,958
Income (loss) from equity method investments(2)	1,076		3,552		(776)		3,852
Foreign currency translation adjustment of equity method investments	(1,394)		(1,618)		(244)		(3,256)
Balance at September 30, 2023	$	55,309	$	68,480	$	9,255	$	133,044

__________________________

(1)Gain on dilution of equity method investments relates to issuances of additional shares of Sayona Mining and Atlantic Lithium, which reduced our ownership interest in both Sayona Mining and Atlantic Lithium.

(2)Certain immaterial, out-of-period amounts, related to our proportionate share of the results of Sayona Mining and Sayona Quebec have been included in our current period results.


	Nine Months Ended September 30, 2023
(in thousands)	Sayona Mining		Sayona Quebec		Atlantic Lithium		Total
Balance at December 31, 2022	$	44,620	$	39,763	$	11,265	$	95,648
Additional investments	550		28,076		41		28,667

Gain on dilution of equity method investments(1)	15,144		—		64		15,208
Income (loss) from equity method investments(2)	(978)		948		(1,535)		(1,565)
Foreign currency translation adjustment of equity method investments	(4,027)		(307)		(580)		(4,914)
Balance at September 30, 2023	$	55,309	$	68,480	$	9,255	$	133,044

__________________________

(2)Certain immaterial, out-of-period amounts, related to our proportionate share of the results of Sayona Mining and Sayona Quebec have been included in our current period results.


	Three Months Ended September 30, 2022
(in thousands)	Sayona Mining		Sayona Quebec		Atlantic Lithium		Total
Balance at June 30, 2022	$	17,118	$	33,047	$	14,069	$	64,234
Additional investments	—		4,032		—		4,032

Gain (loss) on dilution of equity method investments (1)	29,402		—		(35)		29,367
Loss from equity method investments	(228)		(454)		(1,321)		(2,003)
Foreign currency translation adjustment of equity method investments	1,336		—		(133)		1,203
Balance at September 30, 2022	$	47,628	$	36,625	$	12,580	$	96,833

__________________________

(1)Gain (loss) on dilution of equity method investments relates to: (i) issuances of additional shares of Sayona, which reduced our ownership interest in Sayona, and (ii) the exercise of certain Atlantic Lithium stock options and share grants which resulted in a reduction of our ownership in Atlantic Lithium.

Table of Contents


	Nine Months Ended September 30, 2022
(in thousands)	Sayona Mining		Sayona Quebec		Atlantic Lithium		Total
Balance at December 31, 2021	$	18,256	$	25,216	$	15,401	$	58,873
Additional investments	1,076		13,011		—		14,087
Gain (loss) on dilution of equity method investments (1)	29,402		—		(35)		29,367
Loss from equity method investments	(2,507)		(1,647)		(2,393)		(6,547)
Foreign currency translation adjustment of equity method investments	1,401		45		(393)		1,053
Balance at September 30, 2022	$	47,628	$	36,625	$	12,580	$	96,833

__________________________

The following table summarizes the fair value of equity method investments where market values from publicly traded entities are readily available:

As of September 30, 2023

(in thousands)

Sayona Mining

Sayona Quebec

Atlantic Lithium

Fair value

74,784

Not publicly traded

18,404

8.OTHER ASSETS AND LIABILITIES

Other current assets consisted of the following:


(in thousands)	September 30, 2023		December 31, 2022
Investments in equity securities	$	458	$	484
Prepaid and other current assets	3,916		2,128
Total other current assets	$	4,374	$	2,612

As of September 30, 2023, our investments in equity securities consisted of common shares in Ricca, which we acquired as part of a spin-out of Ricca from Atlantic Lithium. Ricca is a private company focused on gold exploration in Africa.

Other non-current assets consisted of the following:


(in thousands)	September 30, 2023		December 31, 2022
Advances to affiliates	$	24,031	$	17,316
Other non-current assets	256		264
Operating lease right-of-use assets	1,447		1,293
Total other non-current assets	$	25,734	$	18,873

Advances to affiliates relate to staged investments for future planned lithium projects. We have a strategic partnership with Atlantic Lithium that includes Atlantic Lithium Ghana. Under our partnership, we entered into a project agreement to acquire a 50% equity interest in Atlantic Lithium Ghana in two phases, each requiring us to make future staged investments in Ewoyaa over a period of time.

We recently completed phase 1, which allows us to acquire a 22.5% equity interest in Atlantic Lithium Ghana by funding Ewoyaa’s exploration and DFS costs and notifying Atlantic Lithium of our intention to proceed with additional funding required under phase 2. We completed funding of exploration and DFS costs, and Atlantic Lithium issued their DFS in June 2023. In August, we supplied Atlantic Lithium with notification of our intent to proceed with additional funding. Our future equity interest ownership under phase 1 remains subject to government approvals required under Ghana’s Mineral and Mining Act. Phase 2 allows us to acquire an additional 27.5% equity interest in Atlantic Lithium Ghana upon completion of funding $70 million for capital costs associated with the development of Ewoyaa. Any cost savings or cost overruns from the initial commitment will be shared equally between Piedmont Lithium and Atlantic Lithium. Upon completion of phases 1 and 2, we expect to have a total equity interest of 50% in Atlantic Lithium Ghana. Atlantic Lithium Ghana, in turn, will hold an 81% interest in the Ewoyaa Project net of the interests which will be held by the

Table of Contents

Ghanaian government, resulting in an effective ownership interest of 40.5% in Ewoyaa, by Piedmont. Funding costs are included in “Other non-current assets” in our consolidated balance sheets as an advance on our future phased investments in Atlantic Lithium Ghana.

Our maximum exposure to a loss as a result of our involvement in Ewoyaa is limited to the total funding paid by Piedmont Lithium to Atlantic Lithium. As of September 30, 2023, we did not own an equity interest in Atlantic Lithium Ghana. We have made advanced payments to Atlantic Lithium for Ewoyaa totaling $2.1 million and $2.7 million during the three months ended September 30, 2023 and 2022, respectively, and $6.9 million, and $9.8 million during the nine months ended September 30, 2023 and 2022, respectively.

Other current liabilities consisted of the following:


(in thousands)	September 30, 2023		December 31, 2022
Operating lease liabilities	$	301	$	124
Accrued provisional revenue adjustment	7,751		—
Total other current liabilities	$	8,052	$	124

We received a $31.6 million partial prepayment on our first sale of spodumene concentrate under a provisional pricing arrangement. We recognize revenue from product sales at a point in time when performance obligations are satisfied under the terms of contracts with our customers. When the final price has not been resolved by the end of a reporting period, we estimate the expected sales price based on the initial price, market pricing and known quality measurements. Differences between payments received and the final estimated sales price, which results in a liability, are recorded as accrued provisional revenue adjustments.

9.EQUITY

We are authorized to issue up to 100,000,000 shares of common stock, par value $0.0001 per share, and 10,000,000 shares of preferred stock, par value $0.0001 per share. We have no outstanding shares of preferred stock.

In February 2023, we received $75 million from LG Chem in exchange for 1,096,535 common shares in Piedmont Lithium at an approximate price of $68.40 per share and in conjunction with a multi-year spodumene concentrate offtake agreement. Share issuance costs associated with the subscription totaled $3.9 million and were accounted for as a reduction in the proceeds from share issuances in the consolidated balance sheets.

In March 2022, we issued 2,012,500 shares under our $500 million automatic shelf registration with an issue price of $65.00 per share to raise gross proceeds of $130.8 million. Share issuance costs associated with the U.S. public offering totaled $8.8 million and were accounted for as a reduction in the proceeds from share issuance in the consolidated balance sheets.

As of September 30, 2023, we had $369.2 million remaining under our shelf registration statement, which expires on September 24, 2024.

10.SEGMENT REPORTING

We report our segment information in the same way management internally organizes the business in assessing performance and making decisions regarding allocation of resources in accordance with ASC Topic 280, “Segment Reporting.” We have a single reportable operating segment that operates as a single business platform. In reaching this conclusion, management considered the definition of the CODM, how the business is defined by the CODM, the nature of the information provided to the CODM, how the CODM uses such information to make operating decisions, and how resources and performance are assessed. The results of operations provided to and analyzed by the CODM are at the consolidated level, and accordingly, key resource decisions and assessment of performance are performed at the consolidated level. We have a single, common management team and our cash flows are reported and reviewed at the consolidated level only with no distinct cash flows at an individual business level.

11.FAIR VALUE OF FINANCIAL INSTRUMENTS

Fair value is the exchange price that would be received for an asset or paid to transfer a liability (exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.

We follow FASB ASC Topic 820, “Fair Value Measurement and Disclosure,” which establishes a three-level valuation hierarchy for disclosure of fair value measurements. The valuation hierarchy categorizes assets and liabilities measured at fair value into one of

Table of Contents

three different levels depending on the observability of the inputs employed in the measurement. The three levels are defined as follows:

Level 1:Quoted prices (unadjusted) for identical assets or liabilities in active markets.

Level 2:Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable for the asset or liability, including quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in inactive markets, inputs other than quoted prices that are observable for the asset or liability, and inputs that are derived from observable market data by correlation or other means.

Level 3:Inputs for the asset or liability that are not based on observable market data (unobservable inputs).

The level within which the financial asset or liability is classified is determined based on the lowest level of significant input to the fair value measurement.

Measurement of Fair Value

Our financial instruments consist primarily of cash and cash equivalents, investments in equity securities, trade and other payables, and long-term debt as follows:

•Other financial instruments—The carrying amounts of cash and cash equivalents, and trade and other payables approximate fair value due to their short-term nature.

•Investments in equity securities—As of September 30, 2023 and December 31, 2022, we had $0.5 million and $0.5 million, respectively, of investments in equity securities which are recorded at fair value based on Level 3 inputs. See Note 8—Other Assets and Liabilities.

•Long-term debt—Principal debt outstanding associated with seller financed loans was $0.2 million and $0.6 million as of September 30, 2023 and December 31, 2022, respectively. The carrying value of our long-term debt approximates its estimated fair value.

Level 3 activity was not material for all periods presented.

12.COMMITMENTS AND CONTINGENCIES

Legal Proceedings

We are involved from time to time in various claims, proceedings, and litigation. We establish reserves for specific legal proceedings when we determine that the likelihood of an unfavorable outcome is probable and the amount of loss can be reasonably estimated.

On July 5, 2022, Brad Thomascik, a purported shareholder of the Company’s equity securities, filed a shareholder derivative lawsuit in the U.S. District Court for the Eastern District of New York. On behalf of the Company, the lawsuit purports to bring claims against certain of the Company’s officers and directors. The complaint alleges that the defendants breached their fiduciary duties in connection with the Company’s statements regarding the timing and status of government permits for Carolina Lithium in North Carolina at various times between March 16, 2018 and July 19, 2021. No litigation demand was made to the Company in connection with this action. The lawsuit focuses on the same public statements as the shareholder derivative suit described above. In September 2022, the parties agreed to a stipulation to stay the proceeding pending resolution of the motion to dismiss in the securities law matters described in the second paragraph of this section, and the Court ordered the case stayed in October 2022. We intend to vigorously defend against these claims. Although there can be no assurance as to the outcome, we do not believe these claims have merit. The potential monetary relief, if any, is not probable and cannot be estimated at this time; accordingly, we have not recorded a liability for this matter.

On October 14, 2021, Vincent Varbaro, a purported holder of Piedmont Australia’s American Depositary Shares and the Company’s equity securities, filed a shareholder derivative suit in the U.S. District Court for the Eastern District of New York, purporting to bring claims on behalf of the Company against certain of the Company’s officers and directors. The complaint alleges that the defendants breached their fiduciary duties in connection with the Company’s statements regarding the timing and status of government permits for Carolina Lithium in North Carolina, at various times between March 16, 2018 and July 19, 2021. No litigation demand was made to the Company in connection with this action. In December 2021, the parties agreed to a stipulation to stay the proceeding pending resolution of the motion to dismiss in the securities law matters described in the immediately preceding paragraph, and the Court ordered the case stayed. We intend to vigorously defend against these claims. Although there can be no assurance as to the outcome,

Table of Contents

we do not believe these claims have merit. The potential monetary relief, if any, is not probable and cannot be estimated at this time; accordingly, we have not recorded a liability for this matter.

On September 8, 2023, the parties in the Thomascik and Varbaro cases stipulated to consolidate the two actions. That stipulation has not yet been acted on by the court.

In July 2021, a lawsuit was filed against us in the U.S. District Court for the Eastern District of New York on behalf of a class of putative plaintiffs claiming violations of the Exchange Act. The complaint alleged, among other things, that we made false and/or misleading statements and/or failed to make disclosure relating to proper and necessary permits. In February 2022, the Court appointed a lead plaintiff in this action, and the lead plaintiff filed an amended complaint in April 2022. On July 18, 2022, we moved to dismiss the amended complaint. On September 1, 2022, the lead plaintiff filed his Memorandum of Law in Opposition to our Motion to Dismiss. On October 7, 2022, we filed our Reply Memorandum in support of our Motion to Dismiss. The Court has yet to rule on our Motion to Dismiss. We intend to vigorously defend against these claims should the amended complaint survive. Although there can be no assurance as to the outcome, we do not believe these claims have merit. The potential monetary relief, if any, is not probable and cannot be estimated at this time, accordingly, we have not recorded a liability for this matter.

Other Commitments and Contingencies

In May 2023, we entered into a community development agreement with the City of Cherryville, North Carolina, whereby we committed to fund $11.0 million as follows: (i) $1.0 million to support certain parks and recreation projects and the reestablishment of a department of recreation, of which $0.5 million was paid in July 2023 and $0.5 million was paid in October 2023, and (ii) $10.0 million paid in annual installments of $0.5 million over a 20-year period commencing upon the first shipment of lithium hydroxide from Carolina Lithium. As part of the agreement, the City of Cherryville relinquished extraterritorial zoning jurisdiction over certain real property owned by Piedmont Lithium to Gaston County, North Carolina.

13.SUBSEQUENT EVENTS

In October 2023, we paid $1.5 million for a 19.9% equity interest in Vinland Lithium, a new entity established with Sokoman Minerals (40.05% owners) and Benton Resources (40.05% owners). Through a staged investment agreement, we can earn up to 62.5% equity interest in Killick Lithium, a wholly-owned subsidiary of Vinland Lithium Inc. that currently holds a 100% interest in the Killick Lithium project, a large prospective lithium project in Newfoundland, Canada.

Table of Contents

Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our financial statements and related notes included elsewhere in our Quarterly Report. References in this Form 10-Q to our Form 10-K refer to our Form 10-K, filed on March 1, 2023, as amended by our Form 10-K/A on April 24, 2023. The following discussion contains forward-looking statements that reflect our plans, estimates, and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to these differences include those discussed below and elsewhere in our Quarterly Report and those in the sections of our Annual Report for the year ended December 31, 2022 entitled “Risk Factors,” “Cautionary Note Regarding Forward-Looking Statements,” and “Cautionary Note Regarding Disclosure of Mineral Properties.”

This management’s discussion and analysis is a supplement to our financial statements, including notes, referenced elsewhere in our Quarterly Report and is provided to enhance your understanding of our operations and financial condition. This discussion is presented in millions, and due to rounding, may not sum or calculate precisely to the totals and percentages provided in the tables.

Executive Overview & Strategy

We are a U.S. development-stage company with the aim of becoming one of the leading producers of lithium hydroxide in North America. As the world, the American government, and industries mobilize to support global decarbonization through the electrification of transportation, we are poised to become a critical contributor to the U.S. electric vehicle and battery manufacturing supply chains.

Since 2021, electric vehicle and battery companies have announced significant commitments to build new or expanded manufacturing operations across the U.S., which is expected to exponentially and rapidly drive the domestic demand for lithium over the next decade, far beyond current or projected capacity. Piedmont Lithium, as a U.S. based company, is well positioned to benefit from federal policies and funding established to facilitate the expedited development of a robust domestic supply chain and clean energy economy, while strengthening national and global energy security. A challenge faced by the industry is that while manufacturing facilities for electric vehicles, batteries, and related components are typically constructed in two to three years, the development of lithium resources from exploration to production requires a much longer time frame. We believe that the prolonged time frame for resource development is the greatest risk to the emerging electrification industry, but also represents opportunities for lithium producers.

To support growing U.S. lithium demand, we have spent the past seven years developing a portfolio of four projects: wholly-owned Tennessee Lithium and Carolina Lithium, strategic investments in Quebec, Canada, with Sayona Mining and Sayona Quebec, and in Ghana with Atlantic Lithium. Our joint venture with Sayona Mining, Sayona Quebec, began supplying spodumene concentrate to the market in the third quarter of 2023. Our future investment in Atlantic Lithium Ghana is expected to produce spodumene concentrate in 2025. We anticipate spodumene concentrate from Ghana will serve as the primary feedstock for Tennessee Lithium. Tennessee Lithium is being designed to produce 30,000 metric tons of lithium hydroxide annually. Carolina Lithium is being developed as a fully integrated spodumene concentrate-to-lithium hydroxide project designed to produce 30,000 metric tons of lithium hydroxide annually.

We currently plan to produce an estimated 60,000 metric tons per year of domestic lithium hydroxide, which would be significantly accretive to today’s total estimated U.S. annual production capacity of just 20,000 metric tons per year. Our lithium hydroxide capacity and revenue generation are expected to be supported by production of, or offtake rights to, approximately 525,000 dmt of spodumene concentrate annually.

Our projects and strategic investments are being developed on a measured timeline to provide the potential for near-term cash flow and long-term value maximization as we explore opportunities to grow our hard rock lithium base through other investments. The development timelines are subject to permitting, regulatory approvals, funding, successful project execution, and market dynamics. We also continue to evaluate opportunities to further expand our resource base and production capacity.

As we continue to advance our goal of becoming one of the leading manufacturers of lithium products in North America, we expect to capitalize on our competitive strengths, including our life-of-mine offtake agreement with Sayona Quebec, scale and diversification of lithium resources, advantageous locations of projects and assets, access to a variety of funding options, opportunities to leverage our greenfield projects, and a highly experienced management team. Advancements that have been made toward this effort are highlighted below.

Table of Contents

Piedmont Lithium

We continue to engage in activities to strengthen our financial position and business strategy, including support for the development and expansion of our portfolio of projects, strategic investments, and corporate operations.

In October 2023, we paid $1.5 million for a 19.9% equity interest in Vinland Lithium, which is a Canadian-based entity jointly owned with Sokoman Minerals and Benton Resources. Vinland Lithium currently owns the Killick Lithium Project, a large exploration property prospective for lithium located in southern Newfoundland, Canada. We have entered into an earn-in agreement with Vinland Lithium to acquire up to a 62.5% equity interest in Killick Lithium through staged-investments. As part of our investment, we entered into a marketing agreement with Killick Lithium for 100% marketing rights and right of first refusal to purchase 100% of all lithium products produced by Killick Lithium on a life-of-mine basis at competitive commercial rates.

Lithium Projects

Quebec

We own equity interests of approximately 12% and 25% in Sayona Mining and Sayona Quebec, respectively. Sayona Mining owns the remaining 75% equity interest in Sayona Quebec. Sayona Quebec owns a portfolio of projects, which includes NAL, the Authier Lithium Project, and the Tansim Lithium Project. We hold a life-of-mine offtake agreement with Sayona Quebec for the greater of 113,000 metric tons or 50% of spodumene concentrate production per year. Our purchases of spodumene concentrate are subject to a price floor of $500 per metric ton and a price ceiling of $900 per metric ton for 6.0% Li2O spodumene concentrate on an FOB North Carolina basis.

Recent highlights include:

•During the three months ended September 30, 2023, NAL produced 31,486 dmt of spodumene concentrate and shipped 48,211 dmt of spodumene concentrate, of which 29,011 dmt spodumene concentrate were sold to Piedmont.

•In October 2023, Sayona Mining provided a forecast for the one-year period July 1, 2023 through June 30, 2024 projecting production of 140,000 to 160,000 dmt of spodumene concentrate and shipments of 160,000 to 180,000 dmt of spodumene concentrate at NAL.

•In November 2023, Sayona announced drill results from the 2023 drill campaign at NAL including significant intercepts of spodumene bearing pegmatites in a Northwest direction from the existing pit shell. Drilling encountered thick, high-grade pegmatites. Additional assay results are pending.

Ghana

We own an equity interest of approximately 9% in Atlantic Lithium, and we have a right to acquire 50% equity interest in Atlantic Lithium Ghana, which includes Atlantic’s flagship Ewoyaa Lithium Project located approximately 70 miles from the Port of Takoradi in Ghana, West Africa. We hold an offtake agreement with Atlantic Lithium for 50% of annual production of spodumene concentrate at market prices on a life-of-mine basis from Ewoyaa. As part of our strategy, we expect to transport our 50% offtake of spodumene concentrate from Ewoyaa to the U.S. to serve as the primary feedstock for lithium hydroxide conversion at Tennessee Lithium.

Recent highlights include:

•In October 2023, Ghana’s Ministry of Lands and Natural Resources granted a mining lease for Ewoyaa, subject to ratification by the Ghanaian Parliament. The mining lease includes a 13% free-carried interest in Ewoyaa for the Government of Ghana, and a 10% royalty. The mining lease remains subject to parliamentary ratification.

•In September 2023, the MIIF entered into a non-binding agreement with Atlantic Lithium to invest $27.9 million to acquire a 6% equity interest in Ewoyaa, with the investment earmarked for Ewoyaa’s project development costs, and to fund 6% of all future exploration and development costs within Atlantic Lithium’s Ghanaian portfolio. MIIF’s investment is expected to equally reduce Piedmont and Atlantic Lithium’s funding requirements for Ewoyaa. If executed, Piedmont and Atlantic Lithium would each own a 40.5% equity interest in Ewoyaa, inclusive of the government’s free-carried interest. Piedmont would continue to maintain a 50% life-of-mine offtake right to future spodumene concentrate production from Atlantic Lithium Ghana under these agreements.

Table of Contents

•In August 2023, we exercised our option to acquire a 22.5% equity interest in Atlantic Lithium Ghana, subject to government approvals, as part of an earn-in agreement to acquire a 50% equity interest in Atlantic Lithium Ghana, excluding the MIIF investment and the government’s free-carried interest. Additionally, we have committed to fund the first $70.0 million of capital expenditures for the development of Ewoyaa, which will allow us to earn the remaining 27.5% equity interest in Atlantic Lithium Ghana. Additional capital costs for development will be shared equally with Atlantic Lithium.

•Atlantic Lithium expects permitting and approvals for Ewoyaa to be finalized in the second half of 2024, with first production from the modular dense medium separation plant expected in the second half of 2025. Full commercial production is targeted for 2026, subject to approval of environmental studies, parliamentary ratification, and other statutory requirements.

Tennessee Lithium

Tennessee Lithium is being designed as a world-class lithium hydroxide facility in America’s emerging “Battery Belt” and is expected to add 30,000 metric tons per year of lithium hydroxide production capacity to the U.S. supply chain. We expect the plant to be one of the most sustainable lithium hydroxide operations in the world and will utilize the Metso:Outotec alkaline pressure leaching technology. Use of this technology is expected to reduce solid waste, create fewer emissions, and improve capital and operating costs relative to incumbent technologies.

Recent highlights include:

•In October 2023, we purchased a tailings storage facility adjacent to the proposed Tennessee Lithium plant site for the placement of inert tailings produced as part of the innovative alkaline pressure leach process. In addition, we agreed to acquire a large industrial complex in close proximity to the Tennessee Lithium plant site. These two acquisitions should result in significant net economic benefits to the project.

•During the third quarter 2023, we engaged advisors to support our funding strategy for the construction of Tennessee Lithium. In consultation with the DOE, we have decided to pursue an ATVM loan under the DOE’s Loan Programs Office, rather than complete the previously announced $141.7 million grant under the Bipartisan Infrastructure Law. We expect that the ATVM loan, if awarded, would cover a significantly larger share of the capital required for the project, strengthening the opportunity for strategic parties to partner with us on the project.

•During the third quarter 2023, we exercised our option to acquire the proposed site of the Tennessee Lithium project and are working with the local authorities towards property closing.

•In July 2023, we received our Conditional Major Non-Title V Construction and Operating Air Permit for Tennessee Lithium from TDEC. With the receipt of the Air Permit for the planned 30,000 metric ton per year lithium hydroxide manufacturing plant, we now hold all the material permits required to begin construction at Tennessee Lithium.

Carolina Lithium

Carolina Lithium is located in the historic Carolina Tin-Spodumene Belt and is being designed as a fully integrated project with mining, spodumene concentrate production, and lithium hydroxide manufacturing on a single site in Gaston County, North Carolina. At full production, Carolina Lithium is expected to produce 30,000 metric tons per year of lithium hydroxide. We are currently engaged in permitting activities with state and local regulatory and governing bodies. Our goal is to obtain the necessary material permits in 2024. We expect to proceed with rezoning following receipt of a state mining permit. Construction will commence upon receipt of required permits, rezoning, local approvals, and project financing activities.

We submitted our mining permit application to the NCDEQ and DEMLR in August 2021. In May 2023, DEMLR issued their third Additional Information Request, seeking further clarification on our plans to address environmental monitoring and mitigation. In September 2023, we submitted a partial draft response. We may, based on feedback to our partial draft response, request an extension of time to respond to the Additional Information Request.

Critical Accounting Polices and Estimates

Our management’s discussion and analysis of our financial condition and results of operations is based on our unaudited consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the consolidated financial statements as well as the reported expenses incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors that we believe are reasonable

Table of Contents

under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

See Significant Accounting Policies section in Note 1—Description of Company for any changes in the significant accounting policies followed by us during the nine months ended September 30, 2023, from those disclosed in our Annual Report for the year ended December 31, 2022.

COVID-19 Response

To protect the health and safety of our employees, contractors, visitors, and communities, we implemented a comprehensive plan in response to the COVID-19 pandemic. Our plan included policies and protocols governing issues such as close contact exposure and contraction of COVID-19 and other communicable diseases, providing employees with additional personal protective equipment and allowing our employees to work remotely. We have provided paid time off for employees impacted by COVID-19, reimbursed employees for costs associated with COVID-19 testing, provided time for employees to get vaccinated, and encouraged flexible work schedules to accommodate personal and family needs. Currently, the rate of COVID-19 outbreaks in the U.S. appears to be significantly reduced, but the possibility of new strains emerging continues to pose a risk. While our business has not been materially impacted, the global economy and our markets have been, and may continue to be, materially and adversely effected by COVID-19. If the impact of COVID-19 is not effectively and timely controlled on a sustained basis going forward, our business operations and financial condition may be materially and adversely effected by factors that we cannot foresee. Any of these factors and other factors beyond our control could have an adverse effect on the overall business environment, cause uncertainties in the regions where we conduct business, cause our business to suffer in ways that we cannot predict and materially and adversely impact our business, financial condition, and results of operations.

Components of our Results of Operations

Revenue

Exploration and Mine Development Costs

We incur costs in resource exploration, evaluation, and development during the different phases of our resource development projects. Exploration costs incurred before the declaration of proven and probable mineral reserves, which primarily include exploration, drilling, engineering, metallurgical testwork, site-specific reclamation, and compensation for employees associated with exploration activities, are expensed as incurred. We have also expensed as incurred engineering costs attributable to the evaluation of land for our future concentrator and chemical plants, feasibility studies and other project expenses that do not qualify for capitalization. After proven and probable mineral reserves are declared, exploration and mine development costs necessary to bring the property to commercial capacity or increase the capacity or useful life will be capitalized.

Selling, General and Administrative Expenses

Selling, general and administrative expenses relate to overhead costs, such as employee compensation and benefits for corporate management and office staff including accounting, legal, human resources, and other support personnel, professional service fees, insurance, and costs associated with maintaining our corporate headquarters. Included in employee compensation costs are cash and stock-based compensation expenses.

Income (Loss) From Equity Method Investments

Income (loss) from equity method investments reflects our proportionate share of the net income (loss) resulting from our investments in Sayona Mining, Sayona Quebec, and Atlantic Lithium. These investments are recorded under the equity method and adjusted each

Table of Contents

period, on a one-quarter lag, for our share of each investee’s income (loss). Our equity method investments are an integral and integrated part of our ongoing operations. We have determined this justifies a more meaningful and transparent presentation of our proportional share of income in our equity method investments as a component of our income (loss) from operations.

Other Income

Other income consists of interest income, interest expense, foreign currency exchange loss, and gain on dilution of equity method investments. Interest income consists of interest earned on our cash and cash equivalents. Interest expense consists of interest incurred on long-term debt related to noncash acquisitions of mining interests financed by sellers for Carolina Lithium as well as interest incurred for lease liabilities. Foreign currency exchange loss relates to our foreign bank accounts denominated in Canadian dollars and Australian dollars and marketable securities denominated in Australian dollars. Gain on dilution of equity method investments relates to our reduction in ownership of Sayona Mining and Atlantic Lithium due to their issuance of additional shares through public offerings and employee stock compensation grants.

Results of Operations

Three Months Ended September 30, 2023 Compared to Three Months Ended September 30, 2022


	Three Months Ended September 30,
(in thousands)	2023			2022			$ Change		% Change
Revenue	$	47,127		$	—		$	47,127	*
Cost of sales	23,363			—			23,363		*
Gross profit	23,764			—			23,764		*
Gross profit margin	50.4		%	—		%
Exploration and mine development costs	471			434			37		8.5%
Selling, general, and administrative expenses	11,185			7,160			4,025		56.2%
Total operating expenses	11,656			7,594			4,062		53.5%
Income (loss) from equity method investments	3,852			(2,003)			5,855		292.3%
Income (loss) from operations	15,960			(9,597)			25,557		266.3%
Other income	8,959			29,684			(20,725)		(72.9%)
Income tax expense	2,028			3,422			(1,394)		(40.7%)
Net income	$	22,891		$	16,665		$	6,226	37.4%

__________________________

* Not meaningful.

Revenue

Revenue was $47.1 million in the three months ended September 30, 2023 from the sale of 29,011 dmt of spodumene concentrate from our purchase offtake agreement with NAL. We had no sales in the three months ended September 30, 2022. The realized price per dmt was $1,624 for the three months ended September 30, 2023. Realized price is the average estimated price, net of certain distribution and other fees, for approximately 5.3% Li2O grade, which includes referenced pricing data up to September 30, 2023, and is subject to final adjustment. The final adjusted price may be higher or lower than the average estimated realized price based future market price movements. We have estimated the final sales pricing based on expected market conditions and known quality measurements. Any adjustments to the sales price will be reflected in subsequent periods.

Gross Profit and Gross Profit Margin

Gross profit was $23.8 million and gross profit margin was 50.4% in the three months ended September 30, 2023. Gross profit and gross profit margin was driven by our preferential offtake supply agreement with NAL, which includes a price ceiling of $900 per dmt. Our realized cost of sales was $805 per dmt in the three months ended September 30, 2023. Realized cost of sales is the average cost of sales including Piedmont’s offtake pricing agreement with NAL for the purchase of spodumene concentrate at a market price subject to a floor of $500 per metric ton and a ceiling of $900 per metric ton, with adjustments for product grade, freight, and insurance.

Table of Contents

Exploration and Mine Development Costs

Exploration and mine development costs increased 8.5%, to $0.5 million in the three months ended September 30, 2023 compared to $0.4 million in the three months ended September 30, 2022. The change was primarily driven by an increase in exploration and engineering activities related to new project targets.

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased $4.0 million, or 56.2%, to $11.2 million in the three months ended September 30, 2023 compared to $7.2 million in the three months ended September 30, 2022. The increase in selling, general and administrative expenses was primarily due to increased professional fees, consulting services, and employee compensation costs related to the hiring of additional management and support staff at our headquarters in Belmont, North Carolina during 2023. Stock-based compensation expense included in selling, general and administrative expenses was $3.0 million and $1.1 million in the three months ended September 30, 2023 and 2022, respectively.

Income (Loss) from Equity Method Investments

Income from equity method investments increased $5.9 million, or 292.3%, to $3.9 million in the three months ended September 30, 2023 compared to loss from equity method investments of $2.0 million in the three months ended September 30, 2022. The current period income reflects our proportionate share of income resulting from our investment in Sayona Mining and their consolidated subsidiary Sayona Quebec. This income was partially offset by our proportionate share of net loss from Atlantic Lithium.

Other Income

Other income decreased $20.7 million, or 72.9%, to $9.0 million in the three months ended September 30, 2023 from $29.7 million in the three months ended September 30, 2022. The decrease was primarily due to our gain on dilution of equity method investments related to Sayona Mining of $8.0 million in the three months ended September 30, 2023, compared to $29.4 million in the three months ended September 30, 2022, which was partially offset by an increase in interest income of $0.7 million for the same comparable period.

Income Tax Expense

Income tax expense was $2.0 million in the three months ended September 30, 2023 compared to $3.4 million in the three months ended September 30, 2022. The decrease in income tax expense was primarily due to the decreased pre-tax impact of the gain on dilution in Sayona Mining for the same comparable period.

Nine Months Ended September 30, 2023 Compared to Nine Months Ended September 30, 2022


	Nine Months Ended September 30,
(in thousands)	2023			2022			$ Change		% Change
Revenue	$	47,127		$	—		$	47,127	*
Costs of sales	23,363			—			23,363		*
Gross profit	23,764			—			23,764		*
Gross profit margin	50.4		%	—		%
Exploration and mine development costs	1,668			1,485			183		12.3%
Selling, general and administrative expenses	31,793			20,200			11,593		57.4%
Total operating expenses	33,461			21,685			11,776		54.3%
Loss from equity method investments	(1,565)			(6,547)			4,982		(76.1)%
Loss from operations	(11,262)			(28,232)			16,970		(60.1)%
Other income	18,045			29,583			(11,538)		(39.0)%
Income tax expense	3,170			3,422			(252)		(7.4)%
Net income (loss)	$	3,613		$	(2,071)		$	5,684	(274.5%)

__________________________

* Not meaningful.

Table of Contents

Revenue

Revenue was $47.1 million in the nine months ended September 30, 2023 from the sale of 29,011 dmt of spodumene concentrate from our purchase offtake agreement with NAL. We had no sales in the nine months ended September 30, 2022. The realized price per dmt was $1,624 for the nine months ended September 30, 2023. Realized price is the average estimated price, net of certain distribution and other fees, for approximate 5.3% Li2O grade, which includes referenced pricing data up to September 30, 2023, and is subject to final adjustment. The final adjusted price may be higher or lower than the average estimated realized price based future market price movements. We have estimated the final sales pricing based on expected market conditions and known quality measurements. Any adjustments to the sales price will be reflected in subsequent periods.

Gross Profit and Gross Profit Margin

Gross profit was $23.8 million and gross profit margin was 50.4%, in the nine months ended September 30, 2023. Gross profit and gross profit margin were driven by our preferential offtake supply agreement with NAL, which includes a price ceiling of $900 per dmt. Our realized cost of sales was $805 per dmt in the nine months ended September 30, 2023. Realized cost of sales is the average cost of sales including Piedmont’s offtake pricing agreement with NAL for the purchase of spodumene concentrate at a market price subject to a floor of $500 per metric ton and a ceiling of $900 per metric ton, with adjustments for product grade, freight, and insurance.

Exploration and Mine Development Costs

Exploration and mine development costs increased $0.2 million, or 12.3%, to $1.7 million in the nine months ended September 30, 2023 compared to $1.5 million in the nine months ended September 30, 2022. The change was primarily driven by an increase in exploration and engineering activities related to new project targets.

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased $11.6 million, or 57.4%, to $31.8 million in the nine months ended September 30, 2023 compared to $20.2 million in the nine months ended September 30, 2022. The increase in selling, general and administrative expenses was primarily due to increased professional fees, consulting fees and increased employee compensation costs related to the hiring of additional management and support staff at our headquarters in Belmont, North Carolina during 2023. Stock-based compensation expense included in selling, general and administrative expenses was $7.3 million and $2.5 million in the nine months ended September 30, 2023 and 2022, respectively.

Loss from Equity Method Investments

Loss from equity method investments decreased $5.0 million, or 76.1%, to $1.6 million in the nine months ended September 30, 2023 compared to $6.5 million in the nine months ended September 30, 2022. The loss reflects our proportionate share of the net loss resulting from our investments in Sayona Mining, Sayona Quebec, and Atlantic Lithium. The change was driven by a decrease in losses from Sayona Quebec, Sayona Mining and Atlantic Lithium of $2.6 million, $1.5 million, $0.9 million, respectively.

Other Income

Other income decreased $11.5 million, or 39.0%, to $18.0 million in the nine months ended September 30, 2023 compared to $29.6 million in the nine months ended September 30, 2022. The decrease was primarily due to our gain on dilution of equity method investments related to Sayona Mining of $15.2 million in the nine months ended September 30, 2023 compared to $29.4 million in the nine months ended September 30, 2022 which was partially offset by an increase in interest income of $2.6 million during the same comparable period.

Income Tax Expense

Income tax expense was $3.2 million in the nine months ended September 30, 2023 compared to income tax expense of $3.4 million in the nine months ended September 30, 2022. The decrease in income tax expense was primarily due to the decreased pre-tax impacts of the gain on dilution in Sayona Mining in the same comparable period.

Table of Contents

Liquidity and Capital Resources

Overview

As of September 30, 2023, we had cash and cash equivalents of $94.5 million compared to $99.2 million as of December 31, 2022. As of September 30, 2023, the vast majority of our cash balances were held in the U.S. A significant portion of our cash balances are covered by FDIC insured limits.

During three months ended September 30, 2023, we generated $25 million in cash from operations as we collected cash from a customer associated with a sale during the quarter. Our predominant source of cash to date has been generated through equity financing from issuances of our common stock. In February 2023, we issued 1,096,535 shares of our common stock at $68.40 per share to LG Chem for $75 million. We received cash proceeds of $71.1 million, which is net of $3.9 million in share issuance costs associated with the private placement. As of September 30, 2023, we had $369.2 million remaining under our shelf registration statement, which expires on September 24, 2024.

Our primary uses of cash during the nine months ended September 30, 2023 consisted of: (i) purchases of real property and associated mining interests of $22.5 million and exploration and development expenditures of $2.4 million associated with Carolina Lithium; (ii) equity investments in Sayona Quebec mainly for the operational restart of NAL totaling $28.1 million; (iii) capital expenditures primarily related to engineering costs of $20.0 million for Tennessee Lithium; and (iv) advances to Atlantic Lithium primarily for exploration and evaluation activities related to our investment in Ewoyaa totaling $6.9 million.

As of September 30, 2023, we had working capital of $79.3 million and long-term debt of less than $0.1 million, net of the current portion of $0.2 million, related to seller financed debt, as discussed above.

Liquidity Outlook

In the fourth quarter of 2023, we expect to receive provisional payments from customers for the shipment of approximately 27,500 dmt of spodumene concentrate. We expect pricing for these shipments to be based on spot-market pricing and the cost to be based on a price ceiling of $900 per dmt in accordance with our offtake agreement with NAL. We expect to fund capital expenditures totaling $18.0 million to $22.0 million primarily for Tennessee Lithium and Carolina Lithium and investments in and advances to affiliates totaling $10.0 million to $14.0 million in the fourth quarter of 2023. Investments in and advances to affiliates include cash contributions to our equity method investees and cash advances to Atlantic Lithium for the Ewoyaa Project.

During the third quarter, we engaged advisors to support our funding strategy for the construction of Tennessee Lithium. In consultation with the DOE, we have decided to pursue an ATVM loan under the DOE’s Loan Programs Office rather than complete the previously announced $141.7 million grant under the Bipartisan Infrastructure Law. We expect that the ATVM loan, if awarded, would cover a significantly larger share of the capital required for the project, thereby strengthening the opportunity for strategic parties to partner with us on the project. We are also in the process of submitting an ATVM loan application for Carolina Lithium. Construction is not planned to commence for either Tennessee Lithium or Carolina Lithium until project financing has been finalized for the respective project.

We plan to meet our liquidity needs through available cash balances and operating cash flows. Our planned cash expenditures for the next twelve months primarily relate to: (i) continued cash advances in strategic investments including Ewoyaa; (ii) real property acquisition costs and engineering activities associated with Tennessee Lithium; (iii) real property and associated mineral rights acquisition costs and continued permitting, engineering, and testing activities associated with Carolina Lithium; and (iv) working capital requirements.

Currently, there are no plans for future cash distributions from any of our equity method investments.

As of September 30, 2023, we had entered into land acquisition contracts in North Carolina and Tennessee totaling $35.0 million, of which we expect to close and fund $10.7 million in the fourth quarter of 2023, $19.8 million in 2024, and $4.5 million in 2025. These amounts do not include closing costs such as attorneys’ fees, taxes, and commissions. We are not obligated to exercise our land option agreements, and we are able to cancel our land acquisition contracts, at our option with de minimis cancellation costs, during the contract due diligence period. Certain land option agreements and land acquisition contracts become binding upon commencement of construction for Carolina Lithium.

Table of Contents

We believe our current cash balances are sufficient to fund our cash requirements for at least the next 12 months. In the event costs were to exceed our planned expenditures, we will reduce or eliminate current and/or planned discretionary spending. If further reductions are required, we will reduce certain non-discretionary expenditures.

Historically, we have been successful raising cash through equity financing; however, no assurances can be given that additional financing will be available in amounts sufficient to meet our needs or on terms that are acceptable to us. If we issue additional shares of our common stock, it would result in dilution to our existing shareholders. There are many factors that could significantly impact our ability to raise funds through equity and debt financing as well as influence the timing of future cash flows. See Part II, Item 1A, “Risk Factors” in this Form 10-Q.

Cash Flows

The following table is a condensed schedule of cash flows provided as part of the discussion of liquidity and capital resources:


(in thousands)	Nine Months Ended September 30,
Net cash provided by (used in):	2023		2022

Operating activities	$	5,403	$	(22,041)
Investing activities	(80,473)		(45,794)
Financing activities	70,318		121,179
Net (decrease) increase in cash and cash equivalents	$	(4,752)	$	53,344

Cash Flows from Operating Activities

Operating activities provided $5.4 million and used $22.0 million in the nine months ended September 30, 2023 and 2022, respectively, resulting in an increase in cash provided by operating activities of $27.4 million. The increase was primarily due to an increase in net income of $19.6 million after adjusting for certain noncash items, including gain on dilution, loss from equity method investments, stock compensation expense, and deferred taxes. Also contributing to the increase was a $7.9 million decrease in working capital.

Cash Flows from Investing Activities

Investing activities used $80.5 million and $45.8 million in the nine months ended September 30, 2023 and 2022, respectively, resulting in an increase in cash used in investing activities of $34.7 million. The increase was primarily due to an increase in investments in affiliates of $14.6 million primarily relating to Sayona Quebec for additional investments to fund the NAL restart. Also contributing to the increase was increased capital expenditures of $19.6 million and $3.4 million for Tennessee Lithium and Carolina Lithium, respectively. These increases were partially offset by a decrease in cash advances to our strategic lithium projects of $3.0 million for exploration and evaluation activities related to phase 1 of Ewoyaa.

Cash Flows from Financing Activities

Financing activities provided $70.3 million and $121.2 million in the nine months ended September 30, 2023 and 2022, respectively, resulting in a decrease in cash provided of $50.9 million. The decrease in cash from financing activities was mainly due to a $51.1 million decrease in net cash proceeds from issuances of our common stock and cash exercises of stock options in the nine months ended September 30, 2023 compared to September 30, 2022 as well as an increase in payments to tax authorities for employee share-based compensation of $0.4 million. This decrease in cash provided was partially offset by a decrease in debt payments totaling $0.6 million.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

Other than the items listed below, there have been no material changes in our risk factors from those disclosed in Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk” in our Annual Report for the year ended December 31, 2022.

The transportation industry is faced with economic inflation and possible recession. A prolonged period of inflation could result in increased interest rates, higher fuel prices, and decreased consumer spending, which could have a negative impact on our business and financial results. The results of these impacts could include supply chain instability, longer lead times, delayed orders, and continued issues with capacity constraints in driver, truck, and shipping container availability.

Table of Contents

Since Russia’s invasion of Ukraine, global supply chains have experienced increased fuel prices. While we do not have direct exposure to these geographies, we cannot predict how global supply chain activities, or the economy at large may be impacted by a prolonged war in Ukraine or sanctions imposed in response to the war.

Item 4. Controls and Procedures.

Our management, under supervision and with the participation of our Chief Executive Officer (our Principal Executive Officer) and Chief Financial Officer (our Principal Financial Officer and Principal Accounting Officer), evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of September 30, 2023. Based on the evaluation of our disclosure controls and procedures, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of September 30, 2023. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.

Changes in Internal Control over Financial Reporting

During the three months ended September 30, 2023, we implemented new controls over revenue transactions accounted for under ASC 606, Revenue from Contracts with Customers. There were no other changes in internal control over financial reporting identified in the evaluation for the quarter ended September 30, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II - OTHER INFORMATION

Item 1. LEGAL PROCEEDINGS.

Information regarding legal proceedings is contained in Note 12—Commitments and Contingencies of the unaudited consolidated financial statements contained in this report and is incorporated herein by reference.

Item 1A. RISK FACTORS.

Other than the items listed below, there have been no material changes in our risk factors from those disclosed in Part I, Item 1A, “Risk Factors” in our Annual Report for the year ended December 31, 2022.

Our cash and cash equivalents could be adversely effected if the financial institutions in which it holds its cash and cash equivalents fail.

We maintain cash deposits in accounts that, at times may exceed the amount of insurance provided on such deposits by the FDIC. If one or more of the financial institutions in which we hold cash deposits fails, we could lose all or a portion of our uninsured cash balances. If access to our cash accounts in the future is impaired, whether temporarily or otherwise, we may be unable to pay our operational expenses such as payroll or make other payments. There can be no assurance that the FDIC will take actions to support deposits in excess of existing FDIC insured limits. If banks and financial institutions enter receivership or become insolvent in the future, including the financial institutions in which we, our equity method investments, or our customers hold cash, our and their ability to access existing cash, cash equivalents, and investments may be threatened and could have a material adverse effect on our business and financial condition. In addition, there is a risk that one or more of our current service providers, financial institutions, and other partners may be adversely affected by the foregoing risks, which could directly affect our ability to conduct our business plans on schedule and on budget.

The planned Tennessee Lithium project will be dependent upon our ability to source spodumene concentrate feedstock to be converted to lithium hydroxide at the facility.

Tennessee Lithium will depend upon sourcing spodumene concentrate to produce lithium hydroxide. We intend to provide spodumene concentrate to Tennessee Lithium from our international assets, primarily Ewoyaa in Ghana. While we do not have reason to believe that spodumene concentrate from Ewoyaa would not be available, we expect there to be options available for exploring alternative sources to feed Tennessee Lithium, if needed, especially given the benefits of the Inflation Reduction Act for producers who supply the U.S. electric vehicle market. However, we cannot guarantee our ability to source spodumene concentrate, and our inability to do so would negatively impact our ability to produce lithium hydroxide in Tennessee.

The Company is dependent on a limited number of customers, which makes it vulnerable to the continued relationship with and financial health of those customers.

Two customers accounted for 100% of the Company’s sales in the three and nine months ended September 30, 2023. The Company’s future prospects may depend on the continued business of a limited number of key customers and on our continued status as a qualified supplier to such customers. The Company cannot guarantee that these key customers will continue to buy products from us at current levels. The loss of a key customer could have a material adverse effect on the Company’s unaudited consolidated financial statements.

Our long-term success depends on our ability to enter into and deliver product under offtake agreements.

We may encounter difficulty entering and fulfilling offtake agreements for our products. We may fail to deliver the product required by such agreements or may experience production costs in excess of the price to be paid to us under such agreements. Our current offtake agreements require us to deliver product meeting certain specifications, including quality thresholds related to chemical composition and grain size. Failure to meet these specifications could result in price adjustments, the rejection of deliveries or termination of the contracts. In addition, our supply agreements contain force majeure provisions allowing temporary suspension of performance by us or the customer during specified events beyond the control of the affected party. As a result of these issues, we may not achieve the revenue or profit we expect to achieve from our offtake agreements. As of the date of this filing, we have entered into two offtake agreements for our lithium products.

On January 2, 2023, we entered into an amended offtake agreement with Tesla to provide spodumene concentrate from NAL in Quebec. The agreement commits us to sell 125,000 metric tons of spodumene concentrate from our offtake agreement with Sayona

Table of Contents

Quebec. The term of the agreement is three years, from the second half of 2023 until the end of 2025, and pricing is determined by a market-based mechanism. The three-year term can be extended for an additional three years upon mutual agreement.

On February 16, 2023, we entered into a spodumene concentrate offtake agreement with LG Chem. The agreement commits us to sell 200,000 metric tons of spodumene concentrate from our offtake agreement with Sayona Quebec. The term of the agreement is four years, beginning in the third quarter of 2023 until the third quarter of 2027 or until we have delivered 200,000 metric tons of spodumene concentrate. Pricing is determined by a market-based mechanism.

Our business, results of operations, and financial condition may be materially and adversely affected if we are unable to enter into similar agreements with other buyers, deliver the products required by such agreements, or incur costs in excess of the price set forth in such agreements.

Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

None.

Item 3. DEFAULTS UPON SENIOR SECURITIES.

None.

Item 4. MINE SAFETY DISCLOSURES.

Not applicable because we do not currently operate any mines subject to the U.S. Federal Mine Safety and Health Act of 1977.

Item 5. OTHER INFORMATION.

On August 17, 2023, Keith Phillips, President and CEO, adopted a rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 30,000 shares of the Company’s common stock until November 29, 2024.

During the three months ended September 30, 2023, no other director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule10b5-1 trading arrangement,” as each term is defined in item 408(a) of Regulation S-K.

Table of Contents

Item 6. EXHIBITS.

Exhibit Index


Exhibit Number			Description
3.1			Amended and Restated Certificate of Incorporation of Piedmont Lithium Inc. (filed with the SEC as Exhibit 3.1 to the Company’s Current Report on Form 8-K12B filed on May 18, 2021)
3.2			Amended and Restated Bylaws of Piedmont Lithium Inc. (filed with the SEC as Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on February 24, 2023)
31.1*			Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*			Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*			Certification of Principal Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*			Certification of Principal Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*			XBRL Instance Document - - embedded within the Inline XBRL document
101.SCH*			XBRL Taxonomy Extension Schema Document
101.CAL*			XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*			XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*			XBRL Taxonomy Extension Label Linkbase Document
101.PRE*			XBRL Taxonomy Extension Presentation Linkbase Document
104*			Cover page Interactive Data file (formatted as Inline XBRL and contained in Exhibit 101).

__________________________

*Filed herewith.

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	Piedmont Lithium Inc.
	(Registrant)

Date: November 9, 2023	By:	/s/ Michael White
		Michael White
		Executive Vice President and Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

Exhibit 31.1

I, Keith D. Phillips, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 of Piedmont Lithium Inc. (the “Company”);

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report;

4.The Company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the Company and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the Company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the Company’s internal control over financial reporting that occurred during the most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting; and

5.The Company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company’s auditors and the audit committee of the Company’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting.


Date:			November 9, 2023

By:			/s/ Keith D. Phillips
Name:			Keith D. Phillips
Title:			President and Chief Executive Officer (Principal Executive Officer)

Exhibit 31.2

I, Michael White, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 of Piedmont Lithium Inc. (the “Company”);

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting.


Date:			November 9, 2023

By:			/s/ Michael White
Name:			Michael White
Title:			Executive Vice President and Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES OXLEY ACT OF 2002

In connection with the Quarterly Report of Piedmont Lithium Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2023 (the “Report”) as filed with the Securities and Exchange Commission on the date hereof, I, Keith D. Phillips, Chief Executive Officer of the Company, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

1.the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act, as amended; and

2.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date:			November 9, 2023

By:			/s/ Keith D. Phillips
Name:			Keith D. Phillips
Title:			President and Chief Executive Officer (Principal Executive Officer)

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES OXLEY ACT OF 2002

In connection with the Quarterly Report of Piedmont Lithium Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2023 (the “Report”) as filed with the Securities and Exchange Commission on the date hereof, I, Michael White, Chief Financial Officer of the Company, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

1.the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act, as amended; and

2.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date:			November 9, 2023

By:			/s/ Michael White
Name:			Michael White
Title:			Executive Vice President and Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

Cover - shares	9 Months Ended
Cover - shares	Sep. 30, 2023	Nov. 03, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2023
Document Transition Report	false
Entity File Number	001-38427
Entity Registrant Name	Piedmont Lithium Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	36-4996461
Entity Address, Address Line One	42 E Catawba Street
Entity Address, City or Town	Belmont
Entity Address, State or Province	NC
Entity Address, Postal Zip Code	28012
City Area Code	704
Local Phone Number	461-8000
Title of 12(b) Security	Common stock, $0.0001 par value per share
Trading Symbol	PLL
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		19,209,327
Amendment Flag	false
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Entity Central Index Key	0001728205
Current Fiscal Year End Date	--12-31

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands

3 Months Ended

9 Months Ended

Sep. 30, 2023

Sep. 30, 2022

Sep. 30, 2023

Sep. 30, 2022

Income Statement [Abstract]

Revenue

$ 47,127

$ 0

$ 47,127

$ 0

Costs of sales

23,363

Gross profit

23,764

Exploration and mine development costs

471

434

1,668

1,485

Selling, general, and administrative expenses

11,185

7,160

31,793

20,200

Total operating expenses

11,656

7,594

33,461

21,685

Income (loss) from equity method investments

^[1]

3,852

(2,003)

(1,565)

(6,547)

Income (loss) from operations

15,960

(9,597)

(11,262)

(28,232)

Interest income

1,031

373

2,959

373

Interest expense

(8)

(21)

(34)

(97)

Loss from foreign currency exchange

(22)

(35)

(88)

(60)

Gain on dilution of equity method investments

^[1]

7,958

29,367

15,208

29,367

Total other income

8,959

29,684

18,045

29,583

Income before taxes

24,919

20,087

6,783

1,351

Income tax expense

2,028

3,422

3,170

3,422

Net income (loss)

$ 22,891

$ 16,665

$ 3,613

$ (2,071)

Earnings (loss) per share:

Basic (in dollars per share)

$ 1.19

$ 0.93

$ 0.19

$ (0.12)

Diluted (in dollars per share)

$ 1.19

$ 0.92

$ 0.19

$ (0.12)

Weighted-average shares outstanding

Basic (in shares)

19,203

17,966

18,974

17,343

Diluted (in shares)

19,239

18,081

19,011

17,343

[1]	Income (loss) from equity method investments and Gain on dilution of equity method investments are reported on a one-quarter lag.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)
$ in Thousands

3 Months Ended

9 Months Ended

Sep. 30, 2023

Sep. 30, 2022

Sep. 30, 2023

Sep. 30, 2022

Statement of Comprehensive Income [Abstract]

Net Income (loss)

$ 22,891

$ 16,665

$ 3,613

$ (2,071)

Other comprehensive income (loss), net of tax:

Foreign currency translation adjustment of equity method investments

^[1]

(2,992)

811

(4,084)

662

Other comprehensive income (loss), net of tax

(2,992)

811

(4,084)

662

Comprehensive income (loss)

$ 19,899

$ 17,476

$ (471)

$ (1,409)

[1]	Foreign currency translation adjustment of equity method investments is presented net of tax (expense) benefit of $264 and $(392) for the three months ended September 30, 2023, and 2022 respectively, and $830 and $(392) for the nine months ended September 30, 2023, and 2022 respectively.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Statement of Comprehensive Income [Abstract]
Foreign currency translation adjustment of equity method investments, tax (expense) benefit	$ 264	$ (392)	$ 830	$ (392)

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Assets
Cash and cash equivalents	$ 94,495	$ 99,247
Accounts receivable	23,281	0
Other current assets	4,374	2,612
Total current assets	122,150	101,859
Property, plant and mine development, net	116,422	71,541
Other non-current assets	25,734	18,873
Equity method investments	133,044	95,648
Total assets	397,350	287,921
Liabilities and Stockholders’ Equity
Accounts payable and accrued expenses	34,607	12,862
Current portion of long-term debt	201	425
Other current liabilities	8,052	124
Total current liabilities	42,860	13,411
Long-term debt, net of current portion	44	163
Operating lease liabilities, net of current portion	1,174	1,177
Deferred tax liabilities	5,221	2,881
Total liabilities	49,299	17,632
Commitments and contingencies (Note 12)
Stockholders’ equity:
Common stock; $0.0001 par value, 100,000 shares authorized; 19,209 and 18,073 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively	2	2
Additional paid-in capital	459,475	381,242
Accumulated deficit	(102,045)	(105,658)
Accumulated other comprehensive loss	(9,381)	(5,297)
Total stockholders’ equity	348,051	270,289
Total liabilities and stockholders’ equity	$ 397,350	$ 287,921

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	100,000,000	100,000,000
Common stock, shares issued (in shares)	19,209,000	18,073,000
Common stock, shares outstanding (in shares)	19,209,000	18,073,000

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands

9 Months Ended

Sep. 30, 2023

Sep. 30, 2022

Cash flows from operating activities:

Net Income (loss)

$ 3,613

$ (2,071)

Adjustments to reconcile net income (loss) to net cash used in operating activities:

Stock-based compensation expense

7,378

2,643

Loss from equity method investments

^[1]

1,565

6,547

Gain on dilution of equity method investments

^[1]

(15,208)

(29,367)

Deferred taxes

3,170

3,422

Depreciation

174

Noncash lease expense

169

Loss on sale of property, plant and mine development

Unrealized loss on investment

Changes in operating assets and liabilities:

Accounts receivable

(23,281)

Other assets

(1,633)

(959)

Operating lease liabilities

(148)

(69)

Accounts payable

21,865

270

Accrued expenses and other current liabilities

7,712

(2,627)

Net cash provided by (used in) operating activities

5,403

(22,041)

Cash flows from investing activities:

Capital expenditures

(44,978)

(21,892)

Advances to affiliates

(6,828)

(9,815)

Investments in equity method investments

(28,667)

(14,087)

Net cash used in investing activities

(80,473)

(45,794)

Cash flows from financing activities:

Proceeds from issuances of common stock, net of issuance costs

71,084

122,059

Proceeds from exercise of stock options

Principal payments on long-term debt

(344)

(973)

Payments to tax authorities for employee stock-based compensation

(422)

Net cash provided by financing activities

70,318

121,179

Net (decrease) increase in cash

(4,752)

53,344

Cash and cash equivalents at beginning of period

99,247

64,245

Cash and cash equivalents at end of period

94,495

117,589

Supplemental disclosure of cash flow information:

Noncash capital expenditures in accounts payable and accrued expenses

5,114

2,227

Cash paid for interest

Capitalized stock-based compensation

$ 193

$ 213

[1]	Income (loss) from equity method investments and Gain on dilution of equity method investments are reported on a one-quarter lag.

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2021		15,894
Beginning balance at Dec. 31, 2021	$ 161,785	$ 2	$ 255,132	$ (92,683)	$ (666)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net (in shares)		2,013
Issuance of common stock, net	122,059		122,059
Stock-based compensation, net of forfeitures	(86)		(86)
Shares issued for exercise/vesting of stock-based compensation awards (in shares)		23
Equity method investment adjustments in other comprehensive (loss) income, net of tax	194				194
Net (loss) income	(9,155)			(9,155)
Ending balance (in shares) at Mar. 31, 2022		17,930
Ending balance at Mar. 31, 2022	274,797	$ 2	377,105	(101,838)	(472)
Beginning balance (in shares) at Dec. 31, 2021		15,894
Beginning balance at Dec. 31, 2021	161,785	$ 2	255,132	(92,683)	(666)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	(2,071)
Ending balance (in shares) at Sep. 30, 2022		17,995
Ending balance at Sep. 30, 2022	285,384	$ 2	380,140	(94,754)	(4)
Beginning balance (in shares) at Mar. 31, 2022		17,930
Beginning balance at Mar. 31, 2022	274,797	$ 2	377,105	(101,838)	(472)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation, net of forfeitures	1,591		1,591
Shares issued for exercise/vesting of stock-based compensation awards (in shares)		35
Shares issued for exercise/vesting of share-based compensation awards	93		94
Equity method investment adjustments in other comprehensive (loss) income, net of tax	(343)				(343)
Net (loss) income	(9,581)			(9,581)
Ending balance (in shares) at Jun. 30, 2022		17,965
Ending balance at Jun. 30, 2022	266,558	$ 2	378,790	(111,419)	(815)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation, net of forfeitures	1,350		1,350
Shares issued for exercise/vesting of stock-based compensation awards (in shares)		30
Equity method investment adjustments in other comprehensive (loss) income, net of tax	811				811
Net (loss) income	16,665			16,665
Ending balance (in shares) at Sep. 30, 2022		17,995
Ending balance at Sep. 30, 2022	$ 285,384	$ 2	380,140	(94,754)	(4)
Beginning balance (in shares) at Dec. 31, 2022	18,073	18,073
Beginning balance at Dec. 31, 2022	$ 270,289	$ 2	381,242	(105,658)	(5,297)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net (in shares)		1,097
Issuance of common stock, net	71,084		71,084
Stock-based compensation, net of forfeitures	1,166		1,166
Shares issued for exercise/vesting of stock-based compensation awards (in shares)		13
Equity method investment adjustments in other comprehensive (loss) income, net of tax	(2,213)				(2,213)
Net (loss) income	(8,639)			(8,639)
Ending balance (in shares) at Mar. 31, 2023		19,183
Ending balance at Mar. 31, 2023	$ 331,687	$ 2	453,492	(114,297)	(7,510)
Beginning balance (in shares) at Dec. 31, 2022	18,073	18,073
Beginning balance at Dec. 31, 2022	$ 270,289	$ 2	381,242	(105,658)	(5,297)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) income	$ 3,613
Ending balance (in shares) at Sep. 30, 2023	19,209	19,209
Ending balance at Sep. 30, 2023	$ 348,051	$ 2	459,475	(102,045)	(9,381)
Beginning balance (in shares) at Mar. 31, 2023		19,183
Beginning balance at Mar. 31, 2023	331,687	$ 2	453,492	(114,297)	(7,510)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation, net of forfeitures	3,266		3,266
Shares issued for exercise/vesting of stock-based compensation awards (in shares)		13
Equity method investment adjustments in other comprehensive (loss) income, net of tax	1,121				1,121
Net (loss) income	(10,639)			(10,639)
Ending balance (in shares) at Jun. 30, 2023		19,196
Ending balance at Jun. 30, 2023	325,435	$ 2	456,758	(124,936)	(6,389)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation, net of forfeitures	3,139		3,139
Shares issued for exercise/vesting of stock-based compensation awards (in shares)		24
Shares surrendered for tax obligations for share-based transactions (in shares)		(11)
Shares surrendered for tax obligations for share-based transactions	(422)		(422)
Equity method investment adjustments in other comprehensive (loss) income, net of tax	(2,992)				(2,992)
Net (loss) income	$ 22,891
Ending balance (in shares) at Sep. 30, 2023	19,209	19,209
Ending balance at Sep. 30, 2023	$ 348,051	$ 2	$ 459,475	$ (102,045)	$ (9,381)

DESCRIPTION OF COMPANY	9 Months Ended
DESCRIPTION OF COMPANY	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
DESCRIPTION OF COMPANY	DESCRIPTION OF COMPANY Nature of Business Piedmont Lithium Inc. (“Piedmont Lithium,” “we,” “our,” “us,” or “Company”) is a U.S. based, development-stage, multi-asset, integrated lithium business in support of a clean energy economy and U.S. and global energy security. We plan to supply lithium hydroxide to the electric vehicle and battery manufacturing supply chains in North America by processing spodumene concentrate produced from assets we own or in which we have an economic interest. Our portfolio of wholly owned projects includes Tennessee Lithium, a proposed merchant lithium hydroxide manufacturing plant in McMinn County, Tennessee, and Carolina Lithium, a proposed, fully integrated spodumene concentrate-to-lithium hydroxide project in Gaston County, North Carolina. The balance of our project portfolio includes strategic investments in lithium assets in Quebec, Canada, including the operating NAL mine, and in Ghana, West Africa with Atlantic Lithium, including Ewoyaa. Basis of Presentation Our unaudited consolidated financial statements and related notes have been prepared on the accrual basis of accounting in conformity with U.S. GAAP and in conformity with the rules and regulations of the SEC. The unaudited consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Our reporting currency is U.S. dollars, and we operate on a calendar fiscal year. Certain information and note disclosures normally included in the consolidated financial statements prepared in accordance with U.S. GAAP have been omitted pursuant to such rules and regulations. Therefore, these unaudited interim consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in our amended Annual Report on Form 10-K/A for the year ended December 31, 2022. These unaudited consolidated financial statements reflect all adjustments and reclassifications that, in the opinion of management, are considered necessary for a fair statement of the results of operations, financial position, and cash flows for the periods presented. The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the year ending December 31, 2023, for any other interim period, or for any other future fiscal year. Use of Estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, assumptions, and allocations that affect amounts reported in the consolidated financial statements and related notes. Significant items that are subject to such estimates and assumptions include, but are not limited to, long-lived assets, fair value of stock-based compensation awards, income tax uncertainties, valuation of deferred tax assets, contingent assets and liabilities, legal claims, asset impairments, provisional revenue adjustments, collectability of receivables and environmental remediation. Actual results could differ due to the uncertainty inherent in the nature of these estimates. We base our estimates and assumptions on current facts, historical experience, and various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. Actual results may differ materially and adversely from our estimates. To the extent there are material differences between estimates and actual results, future results of operations will be affected. Risk and Uncertainties We are subject to a number of risks similar to those of other companies of similar size in our industry, including but not limited to, the success of our exploration and development activities, success of our equity method investments in international projects, permitting and construction delays, the need for additional capital or financing to fund operating losses, competition from substitute products and services, protection of proprietary technology, litigation, and dependence on key individuals. We have accumulated deficits of $102.0 million and $105.7 million as of September 30, 2023 and December 31, 2022, respectively. We have cash available on hand and believe this cash will be sufficient to fund our operations and meet our obligations as they come due for at least one year from the date these unaudited consolidated financial statements are issued. In the event our cash requirements change during the next twelve months, management has the ability and commitment to make corresponding changes to our operating expenses, capital expenditures, and investments as necessary. Until commercial production is achieved from our planned operations, we will continue to incur investing net cash outflows associated with, among other things, funding capital projects, development-stage technical studies, permitting activities associated with our projects, funding our expected commitments in Quebec and Ghana, maintaining and acquiring exploration properties and undertaking ongoing exploration activities. Our long-term success is dependent upon our ability to successfully raise additional capital or financing or enter into strategic partnership opportunities. Our long-term success is also dependent upon our ability to obtain certain permits and approvals, develop our planned portfolio of projects, earn revenues, and achieve profitability. Our unaudited consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. Significant Accounting Policies Revenue Recognition We recognize revenue from product sales at a point in time when performance obligations are satisfied under the terms of contracts with our customers. A performance obligation is deemed to be satisfied when control of the product is transferred to our customer, which is typically upon delivery to the shipping carrier. Where a contract contains more than one distinct performance obligation, the transaction price is allocated to each performance obligation based on the standalone selling price of each performance obligation, although these situations do not occur frequently and are generally not built into our contracts. Revenue is measured as the amount of consideration expected to be received in exchange for transferring the goods. Initial pricing is typically billed 5 days to 30 days after the departure of the shipment and paid between 15 days to 75 days. Final adjustments to prices may take longer to resolve. When the final price has not been resolved by the end of a reporting period, we estimate the expected sales price based on the initial price, market pricing and known quality measurements. We warrant to our customers that our products conform to mutually agreed product specifications. We have elected to account for shipping and handling costs for spodumene concentrate contracts as fulfillment activities and not as promised goods or services; therefore, these activities are not considered separate performance obligations. We have elected the practical expedient relating to significant financing components and as such will not consider the possibility of a contract having a significant financing component (which would effectively attribute a portion of the sales price to interest income) unless, if at contract inception, the expected payment terms (from time of delivery or other relevant criterion) are more than one year. Our lithium products are sold to global and regional customers in the electric vehicle and electronics markets, among others. We currently work with end users in a number of markets to tailor our products to their specifications and will work with these end users as we add more products. There have been no other changes to significant accounting policies described in Note 2—Summary of Significant Accounting Policies within Part II, Item 8 of our Annual Report for the year ended December 31, 2022. Recently Issued and Adopted Accounting Pronouncements We have considered the applicability and impact of all recently issued accounting pronouncements and have determined that they were either not applicable or were not expected to have a material impact on our unaudited consolidated financial statements.

REVENUE	9 Months Ended
REVENUE	Sep. 30, 2023
Revenue from Contract with Customer [Abstract]
REVENUE	REVENUE We recognize revenue from product sales at a point in time when performance obligations are satisfied under the terms of contracts with our customers. A performance obligation is deemed to be satisfied when control of the product is transferred to our customer, which is typically upon delivery to the shipping carrier. There currently are no contracts with multiple performance obligations and there have been no unsatisfied performance obligations. Revenue is measured as the amount of consideration expected to be received in exchange for transferring the goods. Initial pricing is typically billed 5 days to 30 days after the departure of the shipment and paid between 15 days to 75 days. Final adjustments to prices may take longer to resolve. When the final price has not been resolved by the end of a reporting period, we estimate the expected sales price based on the initial price, market pricing and known quality measurements. We warrant to our customers that our products conform to mutually agreed product specifications. In the three and nine months ended September 30, 2023, two customers accounted for 100% of total revenue. All of the sales related to these two customers originated in North America. We evaluate the collectability of our accounts receivable on an individual customer basis. We had no reserve for uncollectible accounts as of September 30, 2023. There are no contract assets or contract liabilities as of September 30, 2023.We are subject to provisional revenue adjustments associated with commodity price fluctuations for our spodumene concentrate sales. These adjustments are unknown until final settlement.

STOCK-BASED COMPENSATION

9 Months Ended

Sep. 30, 2023

Share-Based Payment Arrangement [Abstract]

STOCK-BASED COMPENSATION

Stock Incentive Plans

Stock-based compensation related to all stock-based incentive plans is presented in the following table:


	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
Components of stock-based compensation:
Stock-based compensation	$	3,139	$	1,358	$	7,576	$	3,715
Stock-based compensation forfeitures	—		(8)		(5)		(859)
Stock-based compensation, net of forfeitures	$	3,139	$	1,350	$	7,571	$	2,856

Presentation of stock-based compensation in the unaudited consolidated financial statements:
Exploration and mine development costs	$	57	$	131	$	128	$	133
Selling, general, and administrative expenses	3,010		1,129		7,250		2,510
Stock-based compensation expense, net of forfeitures(1)	3,067		1,260		7,378		2,643
Capitalized stock-based compensation(2)	72		90		193		213
Stock-based compensation, net of forfeitures	$	3,139	$	1,350	$	7,571	$	2,856

__________________________

A summary of activity related to our share-based awards is presented in the following table:


	2023			2022
(in thousands)	Stock Option Awards	Restricted Stock Units	Performance Rights Awards	Stock Option Awards	Restricted Stock Units	Performance Rights Awards
Balance at January 1	265	36	44	273	51	30
Granted	42	40	42	136	17	29
Exercised, surrendered or vested	—	(13)	—	(15)	(14)	—
Forfeited or expired	—	(1)	—	(20)	(17)	—
Balance at March 31	307	62	86	374	37	59
Granted	30	31	27	59	8	10
Exercised, surrendered or vested	—	(12)	—	(38)	(9)	—

Balance at June 30	337	81	113	395	36	69
Granted	—	—	—	—	3	10
Exercised, surrendered or vested	(2)	—	(22)	(37)	(1)	—
Forfeited or expired	—	—	—	—	(1)	—
Balance at September 30	335	81	91	358	37	79

Stock Option Awards

Restricted Stock Unit Awards

Performance Rights Awards

Each performance right converts into one share of common stock upon vesting of performance right.

EARNINGS PER SHARE

9 Months Ended

Sep. 30, 2023

Earnings Per Share [Abstract]

EARNINGS PER SHARE

Basic and diluted net income (loss) per share is reflected in the following table:


	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands, except per share amounts)	2023		2022		2023		2022
Net income (loss)	$	22,891	$	16,665	$	3,613	$	(2,071)

Weighted-average number of common shares used in calculating basic earnings per share	19,203		17,966		18,974		17,343


Effect of potentially dilutive equity awards	36		115		37		—
Weighted-average number of common shares used in calculating dilutive earnings per share	19,239		18,081		19,011		17,343

Basic net income (loss) per weighted-average share	$	1.19	$	0.93	$	0.19	$	(0.12)
Diluted net income (loss) per weighted-average share	$	1.19	$	0.92	$	0.19	$	(0.12)


	Three Months Ended September 30,		Nine Months Ended September 30,
(in thousands)	2023	2022	2023	2022
Stock options	294	223	71	358
RSUs	3	3	10	37
PRAs	94	79	88	79
Total potentially dilutive shares	391	305	169	474

INCOME TAXES	9 Months Ended
INCOME TAXES	Sep. 30, 2023
Income Tax Disclosure [Abstract]
INCOME TAXES	INCOME TAXES We recorded income tax expense of $2.0 million on income before taxes of $24.9 million and a provision of $3.4 million on income before taxes of $20.1 million in the three months ended September 30, 2023 and 2022, respectively. We recorded income tax expense of $3.2 million on income before taxes of $6.8 million and a provision of $3.4 million on income before taxes of $1.4 million in the nine months ended September 30, 2023 and 2022, respectively. The effective tax rates were 8.1% and 17% in the three months ended September 30, 2023 and 2022, respectively, and 46.7% and 253.3% in the nine months ended September 30, 2023 and 2022, respectively. The decrease in income tax expense for the three and nine months ended September 30, 2023 as compared to the three and nine months ended September 30, 2022 was primarily due to a decrease in the gain on dilution in Sayona Mining during the three and nine months ended September 30, 2023. The effective tax rate differs from the U.S. federal statutory rate due to the valuation allowance against our U.S. deferred tax assets and income in foreign jurisdictions taxed at different rates than the U.S. statutory tax rate. We intend to continue maintaining a valuation allowance on our deferred tax assets until there is sufficient evidence to support the reversal of all or some portion of the allowance. However, given our anticipated future earnings, we believe that there is a reasonable possibility that within the next 12 months, sufficient positive evidence may become available to allow us to reach a conclusion that a material portion of the valuation allowance will no longer be needed. Release of the valuation allowance would result in the recognition of certain deferred tax assets and a decrease in income tax expense for the period in which the release is recorded. The exact timing and amount of the valuation allowance release are subject to change based on the level of profitability that we are able to achieve. We continually review the adequacy of our valuation allowance and intend to maintain a valuation allowance on our deferred tax assets where there is not sufficient evidence to support realizability.

PROPERTY, PLANT AND MINE DEVELOPMENT

9 Months Ended

Sep. 30, 2023

Property, Plant and Equipment [Abstract]

PROPERTY, PLANT AND MINE DEVELOPMENT

Property, plant and mine development, net, is presented in the following table:


(in thousands)	September 30, 2023		December 31, 2022
Mining interests	$	78,623	$	56,120
Mine development	4,971		3,050
Land	720		720
Leasehold improvements	401		281
Facilities and equipment	915		675
Construction in process	31,051		10,780
Property, plant and mine development	116,681		71,626
Accumulated depreciation	(259)		(85)
Property, plant and mine development, net	$	116,422	$	71,541

Mining interests and mine development costs relate to Carolina Lithium. Our construction in process primarily relates to capitalized costs associated with Tennessee Lithium.

Depreciation expense is included in “Selling, general and administrative expenses” in our consolidated statements of operations as follows:


	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
Depreciation expense	$	68	$	21	$	174	$	32

EQUITY METHOD INVESTMENTS IN UNCONSOLIDATED AFFILIATES

9 Months Ended

Sep. 30, 2023

Equity Method Investments and Joint Ventures [Abstract]

EQUITY METHOD INVESTMENTS IN UNCONSOLIDATED AFFILIATES

EQUITY METHOD INVESTMENTS

Below is a summary of our equity method investments as of September 30, 2023.

Sayona Mining

Sayona Quebec

Atlantic Lithium

The following tables summarize the carrying amounts, including changes therein, of our equity method investments:


	Three Months Ended September 30, 2023
(in thousands)	Sayona Mining		Sayona Quebec		Atlantic Lithium		Total
Balance at June 30, 2023	$	47,283	$	66,546	$	10,211	$	124,040
Additional investments	450		—		—		450

Gain on dilution of equity method investments(1)	7,894		—		64		7,958
Income (loss) from equity method investments(2)	1,076		3,552		(776)		3,852
Foreign currency translation adjustment of equity method investments	(1,394)		(1,618)		(244)		(3,256)
Balance at September 30, 2023	$	55,309	$	68,480	$	9,255	$	133,044

__________________________

(2)Certain immaterial, out-of-period amounts, related to our proportionate share of the results of Sayona Mining and Sayona Quebec have been included in our current period results.


	Nine Months Ended September 30, 2023
(in thousands)	Sayona Mining		Sayona Quebec		Atlantic Lithium		Total
Balance at December 31, 2022	$	44,620	$	39,763	$	11,265	$	95,648
Additional investments	550		28,076		41		28,667

Gain on dilution of equity method investments(1)	15,144		—		64		15,208
Income (loss) from equity method investments(2)	(978)		948		(1,535)		(1,565)
Foreign currency translation adjustment of equity method investments	(4,027)		(307)		(580)		(4,914)
Balance at September 30, 2023	$	55,309	$	68,480	$	9,255	$	133,044

__________________________

(2)Certain immaterial, out-of-period amounts, related to our proportionate share of the results of Sayona Mining and Sayona Quebec have been included in our current period results.


	Three Months Ended September 30, 2022
(in thousands)	Sayona Mining		Sayona Quebec		Atlantic Lithium		Total
Balance at June 30, 2022	$	17,118	$	33,047	$	14,069	$	64,234
Additional investments	—		4,032		—		4,032

Gain (loss) on dilution of equity method investments (1)	29,402		—		(35)		29,367
Loss from equity method investments	(228)		(454)		(1,321)		(2,003)
Foreign currency translation adjustment of equity method investments	1,336		—		(133)		1,203
Balance at September 30, 2022	$	47,628	$	36,625	$	12,580	$	96,833

__________________________


	Nine Months Ended September 30, 2022
(in thousands)	Sayona Mining		Sayona Quebec		Atlantic Lithium		Total
Balance at December 31, 2021	$	18,256	$	25,216	$	15,401	$	58,873
Additional investments	1,076		13,011		—		14,087
Gain (loss) on dilution of equity method investments (1)	29,402		—		(35)		29,367
Loss from equity method investments	(2,507)		(1,647)		(2,393)		(6,547)
Foreign currency translation adjustment of equity method investments	1,401		45		(393)		1,053
Balance at September 30, 2022	$	47,628	$	36,625	$	12,580	$	96,833

__________________________

The following table summarizes the fair value of equity method investments where market values from publicly traded entities are readily available:

As of September 30, 2023

(in thousands)

Sayona Mining

Sayona Quebec

Atlantic Lithium

Fair value

74,784

Not publicly traded

18,404

OTHER ASSETS AND LIABILITIES

9 Months Ended

Sep. 30, 2023

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

OTHER ASSETS AND LIABILITIES

Other current assets consisted of the following:


(in thousands)	September 30, 2023		December 31, 2022
Investments in equity securities	$	458	$	484
Prepaid and other current assets	3,916		2,128
Total other current assets	$	4,374	$	2,612

Other non-current assets consisted of the following:


(in thousands)	September 30, 2023		December 31, 2022
Advances to affiliates	$	24,031	$	17,316
Other non-current assets	256		264
Operating lease right-of-use assets	1,447		1,293
Total other non-current assets	$	25,734	$	18,873

Other current liabilities consisted of the following:


(in thousands)	September 30, 2023		December 31, 2022
Operating lease liabilities	$	301	$	124
Accrued provisional revenue adjustment	7,751		—
Total other current liabilities	$	8,052	$	124

OTHER ASSETS AND LIABILITIES

Other current assets consisted of the following:


(in thousands)	September 30, 2023		December 31, 2022
Investments in equity securities	$	458	$	484
Prepaid and other current assets	3,916		2,128
Total other current assets	$	4,374	$	2,612

Other non-current assets consisted of the following:


(in thousands)	September 30, 2023		December 31, 2022
Advances to affiliates	$	24,031	$	17,316
Other non-current assets	256		264
Operating lease right-of-use assets	1,447		1,293
Total other non-current assets	$	25,734	$	18,873

Other current liabilities consisted of the following:


(in thousands)	September 30, 2023		December 31, 2022
Operating lease liabilities	$	301	$	124
Accrued provisional revenue adjustment	7,751		—
Total other current liabilities	$	8,052	$	124

EQUITY	9 Months Ended
EQUITY	Sep. 30, 2023
Equity [Abstract]
EQUITY	EQUITY We are authorized to issue up to 100,000,000 shares of common stock, par value $0.0001 per share, and 10,000,000 shares of preferred stock, par value $0.0001 per share. We have no outstanding shares of preferred stock. In February 2023, we received $75 million from LG Chem in exchange for 1,096,535 common shares in Piedmont Lithium at an approximate price of $68.40 per share and in conjunction with a multi-year spodumene concentrate offtake agreement. Share issuance costs associated with the subscription totaled $3.9 million and were accounted for as a reduction in the proceeds from share issuances in the consolidated balance sheets. In March 2022, we issued 2,012,500 shares under our $500 million automatic shelf registration with an issue price of $65.00 per share to raise gross proceeds of $130.8 million. Share issuance costs associated with the U.S. public offering totaled $8.8 million and were accounted for as a reduction in the proceeds from share issuance in the consolidated balance sheets. As of September 30, 2023, we had $369.2 million remaining under our shelf registration statement, which expires on September 24, 2024.

SEGMENT REPORTING	9 Months Ended
SEGMENT REPORTING	Sep. 30, 2023
Segment Reporting [Abstract]
SEGMENT REPORTING	SEGMENT REPORTINGWe report our segment information in the same way management internally organizes the business in assessing performance and making decisions regarding allocation of resources in accordance with ASC Topic 280, “Segment Reporting.” We have a single reportable operating segment that operates as a single business platform. In reaching this conclusion, management considered the definition of the CODM, how the business is defined by the CODM, the nature of the information provided to the CODM, how the CODM uses such information to make operating decisions, and how resources and performance are assessed. The results of operations provided to and analyzed by the CODM are at the consolidated level, and accordingly, key resource decisions and assessment of performance are performed at the consolidated level. We have a single, common management team and our cash flows are reported and reviewed at the consolidated level only with no distinct cash flows at an individual business level.

FAIR VALUE OF FINANCIAL INSTRUMENTS	9 Months Ended
FAIR VALUE OF FINANCIAL INSTRUMENTS	Sep. 30, 2023
Fair Value Disclosures [Abstract]
FAIR VALUE OF FINANCIAL INSTRUMENTS	FAIR VALUE OF FINANCIAL INSTRUMENTS Fair value is the exchange price that would be received for an asset or paid to transfer a liability (exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. We follow FASB ASC Topic 820, “Fair Value Measurement and Disclosure,” which establishes a three-level valuation hierarchy for disclosure of fair value measurements. The valuation hierarchy categorizes assets and liabilities measured at fair value into one of three different levels depending on the observability of the inputs employed in the measurement. The three levels are defined as follows: Level 1:Quoted prices (unadjusted) for identical assets or liabilities in active markets. Level 2:Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable for the asset or liability, including quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in inactive markets, inputs other than quoted prices that are observable for the asset or liability, and inputs that are derived from observable market data by correlation or other means. Level 3:Inputs for the asset or liability that are not based on observable market data (unobservable inputs). The level within which the financial asset or liability is classified is determined based on the lowest level of significant input to the fair value measurement. Measurement of Fair Value Our financial instruments consist primarily of cash and cash equivalents, investments in equity securities, trade and other payables, and long-term debt as follows: •Other financial instruments—The carrying amounts of cash and cash equivalents, and trade and other payables approximate fair value due to their short-term nature. •Investments in equity securities—As of September 30, 2023 and December 31, 2022, we had $0.5 million and $0.5 million, respectively, of investments in equity securities which are recorded at fair value based on Level 3 inputs. See Note 8—Other Assets and Liabilities. •Long-term debt—Principal debt outstanding associated with seller financed loans was $0.2 million and $0.6 million as of September 30, 2023 and December 31, 2022, respectively. The carrying value of our long-term debt approximates its estimated fair value. Level 3 activity was not material for all periods presented.

COMMITMENTS AND CONTINGENCIES	9 Months Ended
COMMITMENTS AND CONTINGENCIES	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES Legal Proceedings We are involved from time to time in various claims, proceedings, and litigation. We establish reserves for specific legal proceedings when we determine that the likelihood of an unfavorable outcome is probable and the amount of loss can be reasonably estimated. On July 5, 2022, Brad Thomascik, a purported shareholder of the Company’s equity securities, filed a shareholder derivative lawsuit in the U.S. District Court for the Eastern District of New York. On behalf of the Company, the lawsuit purports to bring claims against certain of the Company’s officers and directors. The complaint alleges that the defendants breached their fiduciary duties in connection with the Company’s statements regarding the timing and status of government permits for Carolina Lithium in North Carolina at various times between March 16, 2018 and July 19, 2021. No litigation demand was made to the Company in connection with this action. The lawsuit focuses on the same public statements as the shareholder derivative suit described above. In September 2022, the parties agreed to a stipulation to stay the proceeding pending resolution of the motion to dismiss in the securities law matters described in the second paragraph of this section, and the Court ordered the case stayed in October 2022. We intend to vigorously defend against these claims. Although there can be no assurance as to the outcome, we do not believe these claims have merit. The potential monetary relief, if any, is not probable and cannot be estimated at this time; accordingly, we have not recorded a liability for this matter. On October 14, 2021, Vincent Varbaro, a purported holder of Piedmont Australia’s American Depositary Shares and the Company’s equity securities, filed a shareholder derivative suit in the U.S. District Court for the Eastern District of New York, purporting to bring claims on behalf of the Company against certain of the Company’s officers and directors. The complaint alleges that the defendants breached their fiduciary duties in connection with the Company’s statements regarding the timing and status of government permits for Carolina Lithium in North Carolina, at various times between March 16, 2018 and July 19, 2021. No litigation demand was made to the Company in connection with this action. In December 2021, the parties agreed to a stipulation to stay the proceeding pending resolution of the motion to dismiss in the securities law matters described in the immediately preceding paragraph, and the Court ordered the case stayed. We intend to vigorously defend against these claims. Although there can be no assurance as to the outcome, we do not believe these claims have merit. The potential monetary relief, if any, is not probable and cannot be estimated at this time; accordingly, we have not recorded a liability for this matter. On September 8, 2023, the parties in the Thomascik and Varbaro cases stipulated to consolidate the two actions. That stipulation has not yet been acted on by the court. In July 2021, a lawsuit was filed against us in the U.S. District Court for the Eastern District of New York on behalf of a class of putative plaintiffs claiming violations of the Exchange Act. The complaint alleged, among other things, that we made false and/or misleading statements and/or failed to make disclosure relating to proper and necessary permits. In February 2022, the Court appointed a lead plaintiff in this action, and the lead plaintiff filed an amended complaint in April 2022. On July 18, 2022, we moved to dismiss the amended complaint. On September 1, 2022, the lead plaintiff filed his Memorandum of Law in Opposition to our Motion to Dismiss. On October 7, 2022, we filed our Reply Memorandum in support of our Motion to Dismiss. The Court has yet to rule on our Motion to Dismiss. We intend to vigorously defend against these claims should the amended complaint survive. Although there can be no assurance as to the outcome, we do not believe these claims have merit. The potential monetary relief, if any, is not probable and cannot be estimated at this time, accordingly, we have not recorded a liability for this matter. Other Commitments and Contingencies In May 2023, we entered into a community development agreement with the City of Cherryville, North Carolina, whereby we committed to fund $11.0 million as follows: (i) $1.0 million to support certain parks and recreation projects and the reestablishment of a department of recreation, of which $0.5 million was paid in July 2023 and $0.5 million was paid in October 2023, and (ii) $10.0 million paid in annual installments of $0.5 million over a 20-year period commencing upon the first shipment of lithium hydroxide from Carolina Lithium. As part of the agreement, the City of Cherryville relinquished extraterritorial zoning jurisdiction over certain real property owned by Piedmont Lithium to Gaston County, North Carolina.

SUBSEQUENT EVENTS	9 Months Ended
SUBSEQUENT EVENTS	Sep. 30, 2023
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	SUBSEQUENT EVENTSIn October 2023, we paid $1.5 million for a 19.9% equity interest in Vinland Lithium, a new entity established with Sokoman Minerals (40.05% owners) and Benton Resources (40.05% owners). Through a staged investment agreement, we can earn up to 62.5% equity interest in Killick Lithium, a wholly-owned subsidiary of Vinland Lithium Inc. that currently holds a 100% interest in the Killick Lithium project, a large prospective lithium project in Newfoundland, Canada.

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022
Pay vs Performance Disclosure
Net Income (loss)	$ 22,891	$ (10,639)	$ (8,639)	$ 16,665	$ (9,581)	$ (9,155)	$ 3,613	$ (2,071)

Insider Trading Arrangements	3 Months Ended	9 Months Ended
Insider Trading Arrangements	Sep. 30, 2023 shares	Sep. 30, 2023 shares
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Keith Phillips [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On August 17, 2023, Keith Phillips, President and CEO, adopted a rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 30,000 shares of the Company’s common stock until November 29, 2024.
Name	Keith Phillips
Title	President and CEO
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	August 17, 2023
Arrangement Duration	470 days
Aggregate Available	30,000	30,000

DESCRIPTION OF COMPANY (Policies)	9 Months Ended
DESCRIPTION OF COMPANY (Policies)	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation Our unaudited consolidated financial statements and related notes have been prepared on the accrual basis of accounting in conformity with U.S. GAAP and in conformity with the rules and regulations of the SEC. The unaudited consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Our reporting currency is U.S. dollars, and we operate on a calendar fiscal year. Certain information and note disclosures normally included in the consolidated financial statements prepared in accordance with U.S. GAAP have been omitted pursuant to such rules and regulations. Therefore, these unaudited interim consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in our amended Annual Report on Form 10-K/A for the year ended December 31, 2022. These unaudited consolidated financial statements reflect all adjustments and reclassifications that, in the opinion of management, are considered necessary for a fair statement of the results of operations, financial position, and cash flows for the periods presented. The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the year ending December 31, 2023, for any other interim period, or for any other future fiscal year.
Use of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, assumptions, and allocations that affect amounts reported in the consolidated financial statements and related notes. Significant items that are subject to such estimates and assumptions include, but are not limited to, long-lived assets, fair value of stock-based compensation awards, income tax uncertainties, valuation of deferred tax assets, contingent assets and liabilities, legal claims, asset impairments, provisional revenue adjustments, collectability of receivables and environmental remediation. Actual results could differ due to the uncertainty inherent in the nature of these estimates. We base our estimates and assumptions on current facts, historical experience, and various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. Actual results may differ materially and adversely from our estimates. To the extent there are material differences between estimates and actual results, future results of operations will be affected.
Risk and Uncertainties	Risk and Uncertainties We are subject to a number of risks similar to those of other companies of similar size in our industry, including but not limited to, the success of our exploration and development activities, success of our equity method investments in international projects, permitting and construction delays, the need for additional capital or financing to fund operating losses, competition from substitute products and services, protection of proprietary technology, litigation, and dependence on key individuals. We have accumulated deficits of $102.0 million and $105.7 million as of September 30, 2023 and December 31, 2022, respectively. We have cash available on hand and believe this cash will be sufficient to fund our operations and meet our obligations as they come due for at least one year from the date these unaudited consolidated financial statements are issued. In the event our cash requirements change during the next twelve months, management has the ability and commitment to make corresponding changes to our operating expenses, capital expenditures, and investments as necessary. Until commercial production is achieved from our planned operations, we will continue to incur investing net cash outflows associated with, among other things, funding capital projects, development-stage technical studies, permitting activities associated with our projects, funding our expected commitments in Quebec and Ghana, maintaining and acquiring exploration properties and undertaking ongoing exploration activities. Our long-term success is dependent upon our ability to successfully raise additional capital or financing or enter into strategic partnership opportunities. Our long-term success is also dependent upon our ability to obtain certain permits and approvals, develop our planned portfolio of projects, earn revenues, and achieve profitability. Our unaudited consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.
Revenue recognition	Revenue Recognition We recognize revenue from product sales at a point in time when performance obligations are satisfied under the terms of contracts with our customers. A performance obligation is deemed to be satisfied when control of the product is transferred to our customer, which is typically upon delivery to the shipping carrier. Where a contract contains more than one distinct performance obligation, the transaction price is allocated to each performance obligation based on the standalone selling price of each performance obligation, although these situations do not occur frequently and are generally not built into our contracts. Revenue is measured as the amount of consideration expected to be received in exchange for transferring the goods. Initial pricing is typically billed 5 days to 30 days after the departure of the shipment and paid between 15 days to 75 days. Final adjustments to prices may take longer to resolve. When the final price has not been resolved by the end of a reporting period, we estimate the expected sales price based on the initial price, market pricing and known quality measurements. We warrant to our customers that our products conform to mutually agreed product specifications. We have elected to account for shipping and handling costs for spodumene concentrate contracts as fulfillment activities and not as promised goods or services; therefore, these activities are not considered separate performance obligations. We have elected the practical expedient relating to significant financing components and as such will not consider the possibility of a contract having a significant financing component (which would effectively attribute a portion of the sales price to interest income) unless, if at contract inception, the expected payment terms (from time of delivery or other relevant criterion) are more than one year. Our lithium products are sold to global and regional customers in the electric vehicle and electronics markets, among others. We currently work with end users in a number of markets to tailor our products to their specifications and will work with these end users as we add more products.
Recently Issued and Adopted Accounting Pronouncements	Recently Issued and Adopted Accounting Pronouncements We have considered the applicability and impact of all recently issued accounting pronouncements and have determined that they were either not applicable or were not expected to have a material impact on our unaudited consolidated financial statements.
Fair Value of Financial Instruments	Fair value is the exchange price that would be received for an asset or paid to transfer a liability (exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. We follow FASB ASC Topic 820, “Fair Value Measurement and Disclosure,” which establishes a three-level valuation hierarchy for disclosure of fair value measurements. The valuation hierarchy categorizes assets and liabilities measured at fair value into one of three different levels depending on the observability of the inputs employed in the measurement. The three levels are defined as follows: Level 1:Quoted prices (unadjusted) for identical assets or liabilities in active markets. Level 2:Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable for the asset or liability, including quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in inactive markets, inputs other than quoted prices that are observable for the asset or liability, and inputs that are derived from observable market data by correlation or other means. Level 3:Inputs for the asset or liability that are not based on observable market data (unobservable inputs). The level within which the financial asset or liability is classified is determined based on the lowest level of significant input to the fair value measurement.

STOCK-BASED COMPENSATION (Tables)

9 Months Ended

Sep. 30, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of Stock-Based Compensation Expense

Stock-based compensation related to all stock-based incentive plans is presented in the following table:


	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
Components of stock-based compensation:
Stock-based compensation	$	3,139	$	1,358	$	7,576	$	3,715
Stock-based compensation forfeitures	—		(8)		(5)		(859)
Stock-based compensation, net of forfeitures	$	3,139	$	1,350	$	7,571	$	2,856

Presentation of stock-based compensation in the unaudited consolidated financial statements:
Exploration and mine development costs	$	57	$	131	$	128	$	133
Selling, general, and administrative expenses	3,010		1,129		7,250		2,510
Stock-based compensation expense, net of forfeitures(1)	3,067		1,260		7,378		2,643
Capitalized stock-based compensation(2)	72		90		193		213
Stock-based compensation, net of forfeitures	$	3,139	$	1,350	$	7,571	$	2,856

__________________________

Schedule of Share-Based Payment Arrangement, Activity

A summary of activity related to our share-based awards is presented in the following table:


	2023			2022
(in thousands)	Stock Option Awards	Restricted Stock Units	Performance Rights Awards	Stock Option Awards	Restricted Stock Units	Performance Rights Awards
Balance at January 1	265	36	44	273	51	30
Granted	42	40	42	136	17	29
Exercised, surrendered or vested	—	(13)	—	(15)	(14)	—
Forfeited or expired	—	(1)	—	(20)	(17)	—
Balance at March 31	307	62	86	374	37	59
Granted	30	31	27	59	8	10
Exercised, surrendered or vested	—	(12)	—	(38)	(9)	—

Balance at June 30	337	81	113	395	36	69
Granted	—	—	—	—	3	10
Exercised, surrendered or vested	(2)	—	(22)	(37)	(1)	—
Forfeited or expired	—	—	—	—	(1)	—
Balance at September 30	335	81	91	358	37	79

EARNINGS PER SHARE (Tables)

9 Months Ended

Sep. 30, 2023

Earnings Per Share [Abstract]

Schedule of Basic and Diluted Loss per Share

Basic and diluted net income (loss) per share is reflected in the following table:


	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands, except per share amounts)	2023		2022		2023		2022
Net income (loss)	$	22,891	$	16,665	$	3,613	$	(2,071)

Weighted-average number of common shares used in calculating basic earnings per share	19,203		17,966		18,974		17,343


Effect of potentially dilutive equity awards	36		115		37		—
Weighted-average number of common shares used in calculating dilutive earnings per share	19,239		18,081		19,011		17,343

Basic net income (loss) per weighted-average share	$	1.19	$	0.93	$	0.19	$	(0.12)
Diluted net income (loss) per weighted-average share	$	1.19	$	0.92	$	0.19	$	(0.12)

Schedule of Antidilutive Securities Excluded from Calculation of Diluted Net Loss Per Share

The potentially dilutive and anti-dilutive shares not included in diluted net loss per share are presented in the following table:


	Three Months Ended September 30,		Nine Months Ended September 30,
(in thousands)	2023	2022	2023	2022
Stock options	294	223	71	358
RSUs	3	3	10	37
PRAs	94	79	88	79
Total potentially dilutive shares	391	305	169	474

PROPERTY, PLANT AND MINE DEVELOPMENT (Tables)

9 Months Ended

Sep. 30, 2023

Property, Plant and Equipment [Abstract]

Schedule of Property, Plant and Equipment, Net

Property, plant and mine development, net, is presented in the following table:


(in thousands)	September 30, 2023		December 31, 2022
Mining interests	$	78,623	$	56,120
Mine development	4,971		3,050
Land	720		720
Leasehold improvements	401		281
Facilities and equipment	915		675
Construction in process	31,051		10,780
Property, plant and mine development	116,681		71,626
Accumulated depreciation	(259)		(85)
Property, plant and mine development, net	$	116,422	$	71,541

Schedule of Depreciation Expenses

Depreciation expense is included in “Selling, general and administrative expenses” in our consolidated statements of operations as follows:


	Three Months Ended September 30,				Nine Months Ended September 30,
(in thousands)	2023		2022		2023		2022
Depreciation expense	$	68	$	21	$	174	$	32

EQUITY METHOD INVESTMENTS IN UNCONSOLIDATED AFFILIATES (Tables)

9 Months Ended

Sep. 30, 2023

Equity Method Investments and Joint Ventures [Abstract]

Schedule of Equity Method Investments

The following tables summarize the carrying amounts, including changes therein, of our equity method investments:


	Three Months Ended September 30, 2023
(in thousands)	Sayona Mining		Sayona Quebec		Atlantic Lithium		Total
Balance at June 30, 2023	$	47,283	$	66,546	$	10,211	$	124,040
Additional investments	450		—		—		450

Gain on dilution of equity method investments(1)	7,894		—		64		7,958
Income (loss) from equity method investments(2)	1,076		3,552		(776)		3,852
Foreign currency translation adjustment of equity method investments	(1,394)		(1,618)		(244)		(3,256)
Balance at September 30, 2023	$	55,309	$	68,480	$	9,255	$	133,044

__________________________

(2)Certain immaterial, out-of-period amounts, related to our proportionate share of the results of Sayona Mining and Sayona Quebec have been included in our current period results.


	Nine Months Ended September 30, 2023
(in thousands)	Sayona Mining		Sayona Quebec		Atlantic Lithium		Total
Balance at December 31, 2022	$	44,620	$	39,763	$	11,265	$	95,648
Additional investments	550		28,076		41		28,667

Gain on dilution of equity method investments(1)	15,144		—		64		15,208
Income (loss) from equity method investments(2)	(978)		948		(1,535)		(1,565)
Foreign currency translation adjustment of equity method investments	(4,027)		(307)		(580)		(4,914)
Balance at September 30, 2023	$	55,309	$	68,480	$	9,255	$	133,044

__________________________

(2)Certain immaterial, out-of-period amounts, related to our proportionate share of the results of Sayona Mining and Sayona Quebec have been included in our current period results.


	Three Months Ended September 30, 2022
(in thousands)	Sayona Mining		Sayona Quebec		Atlantic Lithium		Total
Balance at June 30, 2022	$	17,118	$	33,047	$	14,069	$	64,234
Additional investments	—		4,032		—		4,032

Gain (loss) on dilution of equity method investments (1)	29,402		—		(35)		29,367
Loss from equity method investments	(228)		(454)		(1,321)		(2,003)
Foreign currency translation adjustment of equity method investments	1,336		—		(133)		1,203
Balance at September 30, 2022	$	47,628	$	36,625	$	12,580	$	96,833

__________________________


	Nine Months Ended September 30, 2022
(in thousands)	Sayona Mining		Sayona Quebec		Atlantic Lithium		Total
Balance at December 31, 2021	$	18,256	$	25,216	$	15,401	$	58,873
Additional investments	1,076		13,011		—		14,087
Gain (loss) on dilution of equity method investments (1)	29,402		—		(35)		29,367
Loss from equity method investments	(2,507)		(1,647)		(2,393)		(6,547)
Foreign currency translation adjustment of equity method investments	1,401		45		(393)		1,053
Balance at September 30, 2022	$	47,628	$	36,625	$	12,580	$	96,833

__________________________

The following table summarizes the fair value of equity method investments where market values from publicly traded entities are readily available:

As of September 30, 2023

(in thousands)

Sayona Mining

Sayona Quebec

Atlantic Lithium

Fair value

74,784

Not publicly traded

18,404

OTHER ASSETS AND LIABILITIES (Tables)

9 Months Ended

Sep. 30, 2023

Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]

Schedule of Other Current Assets

Other current assets consisted of the following:


(in thousands)	September 30, 2023		December 31, 2022
Investments in equity securities	$	458	$	484
Prepaid and other current assets	3,916		2,128
Total other current assets	$	4,374	$	2,612

Schedule of Other Non-current Assets

Other non-current assets consisted of the following:


(in thousands)	September 30, 2023		December 31, 2022
Advances to affiliates	$	24,031	$	17,316
Other non-current assets	256		264
Operating lease right-of-use assets	1,447		1,293
Total other non-current assets	$	25,734	$	18,873

Schedule of Other Current Liabilities

Other current liabilities consisted of the following:


(in thousands)	September 30, 2023		December 31, 2022
Operating lease liabilities	$	301	$	124
Accrued provisional revenue adjustment	7,751		—
Total other current liabilities	$	8,052	$	124

DESCRIPTION OF COMPANY (Details) - USD ($) $ in Thousands	9 Months Ended
DESCRIPTION OF COMPANY (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Disaggregation of Revenue [Line Items]
Accumulated deficit	$ 102,045	$ 105,658
Minimum
Disaggregation of Revenue [Line Items]
Revenue, initial pricing billing period	5 days
Revenue, payment terms	15 days
Maximum
Disaggregation of Revenue [Line Items]
Revenue, initial pricing billing period	30 days
Revenue, payment terms	75 days

REVENUE (Details)	3 Months Ended	9 Months Ended
REVENUE (Details)	Sep. 30, 2023 USD ($)	Sep. 30, 2023 USD ($)
Disaggregation of Revenue [Line Items]
Reserve for uncollectible accounts	$ 0	$ 0
Contract assets	0	0
Contract liabilities	$ 0	$ 0
Two Largest Customers \| Revenue from Contract with Customer Benchmark \| Customer Concentration Risk
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	100.00%	100.00%
Minimum
Disaggregation of Revenue [Line Items]
Revenue, initial pricing billing period		5 days
Revenue, payment terms		15 days
Maximum
Disaggregation of Revenue [Line Items]
Revenue, initial pricing billing period		30 days
Revenue, payment terms		75 days

STOCK-BASED COMPENSATION - Additional Information (Details) $ in Millions	9 Months Ended
	Sep. 30, 2023 USD ($) shares	Jun. 30, 2023 shares	Mar. 31, 2023 shares	Dec. 31, 2022 shares	Sep. 30, 2022 shares	Jun. 30, 2022 shares	Mar. 31, 2022 shares	Dec. 31, 2021 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Awards cost not yet recognized, amount \| $	$ 10.9
Milestone PRAs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested awards expiring over the next three years (in shares)	22,000
TSR PRAs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested awards expiring over the next three years (in shares)	69,000
Assumption of TSR Goal achievement, percent	100.00%
TSR PRAs \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rights, percentage of target amount	0.00%
Expected term (in years)	1 year
TSR PRAs \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rights, percentage of target amount	200.00%
Expected term (in years)	3 years
Performance Rights Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested awards expiring over the next three years (in shares)	91,000	113,000	86,000	44,000	79,000	69,000	59,000	30,000
Award conversion ratio	1
Stock Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years
Expiration period	10 years
Number of common stock available for issuance (in shares)	2,143,116

STOCK-BASED COMPENSATION - Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation	$ 3,139	$ 1,358	$ 7,576	$ 3,715
Stock-based compensation forfeitures	0	(8)	(5)	(859)
Stock-based compensation, net of forfeitures	3,139	1,350	7,571	2,856
Stock-based compensation expense, net of forfeitures	3,067	1,260	7,378	2,643
Capitalized stock-based compensation	72	90	193	213
Stock-based compensation, net of forfeitures	3,139	1,350	7,571	2,856
Exploration and mine development costs
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense, net of forfeitures	57	131	128	133
Selling, general, and administrative expenses
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense, net of forfeitures	$ 3,010	$ 1,129	$ 7,250	$ 2,510

STOCK-BASED COMPENSATION - Schedule of Share-based Awards Activity (Details) - shares shares in Thousands	3 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022
Stock Option Awards
Outstanding at beginning of period (in shares)	337	307	265	395	374	273
Granted (in shares)	0	30	42	0	59	136
Exercised, surrendered or vested (in shares)	(2)	0	0	(37)	(38)	(15)
Forfeited or expired (in shares)	0		0	0		(20)
Outstanding at end of period (in shares)	335	337	307	358	395	374
Restricted Stock Units
Restricted Stock Units & Performance Rights Awards
Unvested at beginning of period (in shares)	81	62	36	36	37	51
Granted (in shares)	0	31	40	3	8	17
Exercised, surrendered or vested (in shares)	0	(12)	(13)	(1)	(9)	(14)
Forfeited or expired (in shares)	0		(1)	(1)		(17)
Unvested at end of period (in shares)	81	81	62	37	36	37
Performance Rights Awards
Restricted Stock Units & Performance Rights Awards
Unvested at beginning of period (in shares)	113	86	44	69	59	30
Granted (in shares)	0	27	42	10	10	29
Exercised, surrendered or vested (in shares)	(22)	0	0	0	0	0
Forfeited or expired (in shares)	0		0	0		0
Unvested at end of period (in shares)	91	113	86	79	69	59

EARNINGS PER SHARE - Schedule of Basic and Diluted Loss per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Earnings Per Share [Abstract]
Net income (loss), basic	$ 22,891	$ 16,665	$ 3,613	$ (2,071)
Net income (loss), diluted	$ 22,891	$ 16,665	$ 3,613	$ (2,071)
Weighted-average number of common shares used in calculating basic earnings per share (in shares)	19,203	17,966	18,974	17,343
Effect of potentially dilutive equity awards (in shares)	36	115	37	0
Weighted-average number of common shares used in calculating dilutive earnings per share (in shares)	19,239	18,081	19,011	17,343
Basic net income (loss) per weighted-average share (in dollars per share)	$ 1.19	$ 0.93	$ 0.19	$ (0.12)
Diluted net income (loss) per weighted-average share (in dollars per share)	$ 1.19	$ 0.92	$ 0.19	$ (0.12)

EARNINGS PER SHARE - Schedule of Antidilutive Securities Excluded from Calculation of Diluted Net Loss Per Share (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potential common shares considered anti-dilutive (in shares)	391	305	169	474
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potential common shares considered anti-dilutive (in shares)	294	223	71	358
RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potential common shares considered anti-dilutive (in shares)	3	3	10	37
PRAs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potential common shares considered anti-dilutive (in shares)	94	79	88	79

INCOME TAXES (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
INCOME TAXES (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Income tax expense	$ 2,028	$ 3,422	$ 3,170	$ 3,422
Income before taxes	$ 24,919	$ 20,087	$ 6,783	$ 1,351
Effective tax rate	8.10%	17.00%	46.70%	253.30%

PROPERTY, PLANT AND MINE DEVELOPMENT (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Property, plant and mine development	$ 116,681	$ 71,626
Accumulated depreciation	(259)	(85)
Property, plant and mine development, net	116,422	71,541
Mining interests
Property, Plant and Equipment [Line Items]
Property, plant and mine development	78,623	56,120
Mine development
Property, Plant and Equipment [Line Items]
Property, plant and mine development	4,971	3,050
Land
Property, Plant and Equipment [Line Items]
Property, plant and mine development	720	720
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant and mine development	401	281
Facilities and equipment
Property, Plant and Equipment [Line Items]
Property, plant and mine development	915	675
Construction in process
Property, Plant and Equipment [Line Items]
Property, plant and mine development	$ 31,051	$ 10,780

PROPERTY, PLANT AND MINE DEVELOPMENT - Schedule of Depreciation Expenses (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Property, Plant and Equipment [Line Items]
Depreciation expense			$ 174	$ 32
Selling, general, and administrative expenses
Property, Plant and Equipment [Line Items]
Depreciation expense	$ 68	$ 21	$ 174	$ 32

EQUITY METHOD INVESTMENTS IN UNCONSOLIDATED AFFILIATES - Additional Information (Details)
t in Thousands, $ in Thousands

3 Months Ended

9 Months Ended

Sep. 30, 2023

USD ($)

$ / t

investment

Sep. 30, 2022

USD ($)

Sep. 30, 2023

USD ($)

$ / t

investment

Sep. 30, 2022

USD ($)

Schedule of Equity Method Investments [Line Items]

Number of equity method investments | investment

Gain on dilution of equity method investments

^[1]

$ 7,958

$ 29,367

$ 15,208

$ 29,367

Sayona Quebec

Schedule of Equity Method Investments [Line Items]

Long-term supply agreement, spodumene concentrate production | t

113

Long-term supply agreement, spodumene concentrate production, percentage

50.00%

Long-term supply agreement, floor price (in dollars per Tonne) | $ / t

500

Long-term supply agreement, ceiling price (in dollars per Tonne) | $ / t

900

Long-term supply agreement, spodumene concentrate percentage

6.00%

Atlantic Lithium

Schedule of Equity Method Investments [Line Items]

Long-term supply agreement, percentage of spodumene concentrate produced for sale

50.00%

Sayona Quebec | North American Lithium Mining

Schedule of Equity Method Investments [Line Items]

Noncontrolling interest, ownership percentage by parent

100.00%

Sayona Mining

Schedule of Equity Method Investments [Line Items]

Equity interest, ownership percentage

12.00%

Gain on dilution of equity method investments

$ 7,894

29,402

$ 15,144

29,402

Sayona Quebec

Schedule of Equity Method Investments [Line Items]

Equity interest, ownership percentage

25.00%

Gain on dilution of equity method investments

$ 0

Sayona Quebec | Sayona Mining

Schedule of Equity Method Investments [Line Items]

Equity interest, ownership percentage

75.00%

Atlantic Lithium

Schedule of Equity Method Investments [Line Items]

Equity interest, ownership percentage

9.00%

Gain on dilution of equity method investments

$ 64

$ (35)

$ 64

$ (35)

Equity interest, right to acquire ownership percentage

50.00%

[1]	Income (loss) from equity method investments and Gain on dilution of equity method investments are reported on a one-quarter lag.

EQUITY METHOD INVESTMENTS IN UNCONSOLIDATED AFFILIATES - Summary of Changes in Equity Method Investments (Details) - USD ($)
$ in Thousands

3 Months Ended

9 Months Ended

Sep. 30, 2023

Sep. 30, 2022

Sep. 30, 2023

Sep. 30, 2022

Increase (Decrease) in Equity Method Investment [Roll Forward]

Equity method investments, beginning balance

$ 124,040

$ 64,234

$ 95,648

$ 58,873

Additional investments

450

4,032

28,667

14,087

Gain (loss) on dilution of equity method investments

^[1]

7,958

29,367

15,208

29,367

Income (loss) from equity method investments

^[1]

3,852

(2,003)

(1,565)

(6,547)

Foreign currency translation adjustment of equity method investments

(3,256)

1,203

(4,914)

1,053

Equity method investments, ending balance

133,044

96,833

133,044

96,833

Sayona Mining

Increase (Decrease) in Equity Method Investment [Roll Forward]

Equity method investments, beginning balance

47,283

17,118

44,620

18,256

Additional investments

450

550

1,076

Gain (loss) on dilution of equity method investments

7,894

29,402

15,144

29,402

Income (loss) from equity method investments

1,076

(228)

(978)

(2,507)

Foreign currency translation adjustment of equity method investments

(1,394)

1,336

(4,027)

1,401

Equity method investments, ending balance

55,309

47,628

55,309

47,628

Fair value

74,784

Sayona Quebec

Increase (Decrease) in Equity Method Investment [Roll Forward]

Equity method investments, beginning balance

66,546

33,047

39,763

25,216

Additional investments

4,032

28,076

13,011

Gain (loss) on dilution of equity method investments

Income (loss) from equity method investments

3,552

(454)

948

(1,647)

Foreign currency translation adjustment of equity method investments

(1,618)

(307)

Equity method investments, ending balance

68,480

36,625

68,480

36,625

Atlantic Lithium

Increase (Decrease) in Equity Method Investment [Roll Forward]

Equity method investments, beginning balance

10,211

14,069

11,265

15,401

Additional investments

Gain (loss) on dilution of equity method investments

(35)

Income (loss) from equity method investments

(776)

(1,321)

(1,535)

(2,393)

Foreign currency translation adjustment of equity method investments

(244)

(133)

(580)

(393)

Equity method investments, ending balance

9,255

$ 12,580

9,255

$ 12,580

Fair value

$ 18,404

[1]	Income (loss) from equity method investments and Gain on dilution of equity method investments are reported on a one-quarter lag.

OTHER ASSETS AND LIABILITIES - Schedule of Other Current Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Investments in equity securities	$ 458	$ 484
Prepaid and other current assets	3,916	2,128
Total other current assets	$ 4,374	$ 2,612

OTHER ASSETS AND LIABILITIES - Schedule of Other Non-current Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Advances to affiliates	$ 24,031	$ 17,316
Other non-current assets	256	264
Operating lease right-of-use assets	1,447	1,293
Total other non-current assets	$ 25,734	$ 18,873

OTHER ASSETS AND LIABILITIES - Additional Information (Details)	3 Months Ended		9 Months Ended
	Sep. 30, 2023 USD ($) phase	Sep. 30, 2022 USD ($)	Sep. 30, 2023 USD ($) phase	Sep. 30, 2022 USD ($)	Jun. 30, 2023 USD ($)	Dec. 31, 2022 USD ($)	Jun. 30, 2022 USD ($)	Dec. 31, 2021 USD ($)
Schedule of Equity Method Investments [Line Items]
Equity method investments	$ 133,044,000	$ 96,833,000	$ 133,044,000	$ 96,833,000	$ 124,040,000	$ 95,648,000	$ 64,234,000	$ 58,873,000
Equity method investments, advance payments	$ 450,000	4,032,000	$ 28,667,000	14,087,000
Minimum
Schedule of Equity Method Investments [Line Items]
Revenue, initial pricing billing period			5 days
Maximum
Schedule of Equity Method Investments [Line Items]
Revenue, initial pricing billing period			30 days
Ghana Project
Schedule of Equity Method Investments [Line Items]
Strategic partnership investments, percentage expected	50.00%		50.00%
Strategic partnership investments, number of phases \| phase	2		2
Equity method investments	$ 0		$ 0
Equity method investments, advance payments	$ 2,100,000	$ 2,700,000	6,900,000	$ 9,800,000
Prepayment			$ 31,600,000
Ghana Project, Phase One
Schedule of Equity Method Investments [Line Items]
Strategic partnership investments, percentage expected	22.50%		22.50%
Ghana Project, Phase Two
Schedule of Equity Method Investments [Line Items]
Strategic partnership investments, percentage expected	27.50%		27.50%
Strategic partnership investments, funding amount	$ 70,000,000		$ 70,000,000
Ewoyaa Project
Schedule of Equity Method Investments [Line Items]
Strategic partnership investments, percentage expected	81.00%		81.00%
Equity interest, ownership percentage	40.50%		40.50%

OTHER ASSETS AND LIABILITIES - Schedule of Other Current Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Operating lease liabilities	$ 301	$ 124
Accrued provisional revenue adjustment	7,751	0
Total other current liabilities	$ 8,052	$ 124

EQUITY (Details) - USD ($)	1 Months Ended
EQUITY (Details) - USD ($)	Feb. 28, 2023	Mar. 31, 2022	Sep. 30, 2023	Dec. 31, 2022
Class of Stock [Line Items]
Common stock, shares authorized (in shares)			100,000,000	100,000,000
Common stock, par value (in dollars per share)			$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)			10,000,000
Preferred stock, par value (in dollars per share)			$ 0.0001
Preferred stock, shares outstanding (in shares)			0
Shelf Registration Program
Class of Stock [Line Items]
Proceeds from sale of stock		$ 130,800,000
Number of shares sold (in shares)		2,012,500
Sale of stock, price (in dollars per share)		$ 65.00
Sale of stock, offering capacity		$ 500,000,000
Remaining offering capacity			$ 369,200,000
U.S. Public Offering Program
Class of Stock [Line Items]
Stock issuance costs		$ 8,800,000
LG Chem
Class of Stock [Line Items]
Proceeds from sale of stock	$ 75,000,000
Number of shares sold (in shares)	1,096,535
Sale of stock, price (in dollars per share)	$ 68.40
Stock issuance costs	$ 3,900,000

SEGMENT REPORTING (Details)	9 Months Ended
SEGMENT REPORTING (Details)	Sep. 30, 2023 segment
Segment Reporting [Abstract]
Number of Reportable Segments	1

FAIR VALUE OF FINANCIAL INSTRUMENTS (Details) - USD ($) $ in Millions	Sep. 30, 2023	Dec. 31, 2022
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Long-term debt	$ 0.2	$ 0.6
Level 3
Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]
Fair value of equity investments	$ 0.5	$ 0.5

COMMITMENTS AND CONTINGENCIES (Details) $ in Millions	1 Months Ended
COMMITMENTS AND CONTINGENCIES (Details) $ in Millions	Oct. 31, 2023 USD ($)	Jul. 31, 2023 USD ($)	May 31, 2023 USD ($)	Sep. 08, 2023 action
Other Commitments [Line Items]
Number of actions consolidated \| action				2
Other commitment			$ 11.0
Community development agreement, amount to support parks and recreation projects			1.0
Community development agreement, parks and recreation projects, payment amount		$ 0.5
Community development agreement, amount paid in annual installments			10.0
Community development agreement, annual payment			$ 0.5
Community development agreement, amount paid in annual installments, period			20 years
Subsequent Event
Other Commitments [Line Items]
Community development agreement, parks and recreation projects, payment amount	$ 0.5

SUBSEQUENT EVENTS (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended		9 Months Ended
SUBSEQUENT EVENTS (Details) - USD ($) $ in Thousands	Oct. 31, 2023	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Subsequent Event [Line Items]
Payments to acquire equity interest		$ 450	$ 4,032	$ 28,667	$ 14,087
Subsequent Event \| Killick Lithium \| Killick Lithium Project
Subsequent Event [Line Items]
Project ownership percentage	100.00%
Subsequent Event \| Vinland Lithium \| Sokoman Minerals
Subsequent Event [Line Items]
Noncontrolling owner's ownership percentage	40.05%
Subsequent Event \| Vinland Lithium \| Benton Resources
Subsequent Event [Line Items]
Noncontrolling owner's ownership percentage	40.05%
Vinland Lithium \| Subsequent Event
Subsequent Event [Line Items]
Payments to acquire equity interest	$ 1,500
Equity interest, ownership percentage	19.90%
Killick Lithium \| Subsequent Event \| Maximum
Subsequent Event [Line Items]
Equity interest, ownership percentage	62.50%